Activation	O
of	O
the	O
HIV-1	B-DNA
enhancer	I-DNA
by	O
the	O
LEF-1	B-protein
HMG	I-protein
protein	I-protein
on	O
nucleosome-assembled	B-DNA
DNA	I-DNA
in	O
vitro	O
.	O

Lymphoid	B-protein
enhancer-binding	I-protein
factor	I-protein
1	I-protein
(	O
LEF-1	B-protein
)	O
is	O
a	O
regulatory	B-protein
high	I-protein
mobility	I-protein
group	I-protein
(	I-protein
HMG	I-protein
)	I-protein
protein	I-protein
that	O
activates	O
the	O
T	B-DNA
cell	I-DNA
receptor	I-DNA
alpha	I-DNA
(	I-DNA
TCR	I-DNA
alpha	I-DNA
)	I-DNA
enhancer	I-DNA
in	O
a	O
context-restricted	O
manner	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

In	O
this	O
paper	O
we	O
demonstrate	O
that	O
the	O
distal	O
region	O
of	O
the	O
human	B-DNA
immunodeficiency	I-DNA
virus-1	I-DNA
(	I-DNA
HIV-1	I-DNA
)	I-DNA
enhancer	I-DNA
,	O
which	O
contains	O
DNA-binding	B-DNA
sites	I-DNA
for	O
LEF-1	B-protein
and	O
Ets-1	O
,	O
also	O
provides	O
a	O
functional	O
context	O
for	O
activation	O
by	O
LEF-1	B-protein
.	O

First	O
,	O
we	O
show	O
that	O
mutations	O
in	O
the	O
LEF-1-binding	B-DNA
site	I-DNA
inhibit	O
the	O
activity	O
of	O
multimerized	B-DNA
copies	I-DNA
of	O
the	O
HIV-1	B-DNA
enhancer	I-DNA
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
,	O
and	O
that	O
LEF-1/GAL4	B-protein
can	O
activate	O
a	O
GAL4-substituted	B-DNA
HIV-1	I-DNA
enhancer	I-DNA
80-	O
to	O
100-fold	O
in	O
vivo	O
.	O

Second	O
,	O
recombinant	B-protein
LEF-1	I-protein
is	O
shown	O
to	O
activate	O
HIV-1	O
transcription	O
on	O
chromatin-assembled	B-DNA
DNA	I-DNA
in	O
vitro	O
.	O

By	O
using	O
a	O
nucleosome	B-protein
-assembly	O
system	O
derived	O
from	O
Drosophila	O
embryos	O
,	O
we	O
find	O
that	O
the	O
packaging	O
of	O
DNA	O
into	O
chromatin	B-DNA
in	O
vitro	O
strongly	O
represses	O
HIV-1	O
transcription	O
and	O
that	O
repression	O
can	O
be	O
counteracted	O
efficiently	O
by	O
preincubation	O
of	O
the	O
DNA	O
with	O
LEF-1	B-protein
(	O
or	O
LEF-1	B-protein
and	O
Ets-1	B-protein
)	O
supplemented	O
with	O
fractions	O
containing	O
the	O
promoter-binding	B-protein
protein	I-protein
,	O
Sp1	B-protein
.	O

Addition	O
of	O
TFE-3	B-protein
,	O
which	O
binds	O
to	O
an	O
E-box	B-DNA
motif	I-DNA
upstream	O
of	O
the	O
LEF-1	B-DNA
and	I-DNA
Ets-1	I-DNA
sites	I-DNA
,	O
further	O
augments	O
transcription	O
in	O
this	O
system	O
.	O

Individually	O
or	O
collectively	O
,	O
none	O
of	O
the	O
three	O
enhancer-binding	B-protein
proteins	I-protein
(	O
LEF-1	B-protein
,	O
Ets-1	B-protein
,	O
and	O
TFE-3	B-protein
)	O
could	O
activate	O
transcription	O
in	O
the	O
absence	O
of	O
Sp1	B-protein
.	O

A	O
truncation	B-protein
mutant	I-protein
of	O
LEF-1	B-protein
(	O
HMG-88	B-protein
)	O
,	O
which	O
contains	O
the	O
HMG	B-protein
box	I-protein
but	O
lacks	O
the	O
trans-activation	B-protein
domain	I-protein
,	O
did	O
not	O
activate	O
transcription	O
from	O
nucleosomal	B-DNA
DNA	I-DNA
,	O
indicating	O
that	O
bending	O
of	O
DNA	O
by	O
the	O
HMG	B-protein
domain	I-protein
is	O
not	O
sufficient	O
to	O
activate	O
transcription	O
in	O
vitro	O
.	O

We	O
conclude	O
that	O
transcription	O
activation	O
by	O
LEF-1	B-protein
in	O
vitro	O
is	O
a	O
chromatin	B-DNA
-dependent	O
process	O
that	O
requires	O
a	O
functional	O
trans-activation	B-protein
domain	I-protein
in	O
addition	O
to	O
the	O
HMG	B-protein
domain	I-protein
.	O

Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Activation	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
by	NULL
the	NULL
LEF-1	NULL
HMG	NULL
protein	NULL
on	NULL
nucleosome-assembled	NULL
DNA	NULL
in	NULL
vitro	NULL
Philip	NULL
L.	NULL
Sheridan	NULL
,	NULL
``	NULL
Christian	NULL
T.	NULL
Sheline	NULL
,	NULL
*~	NULL
Keith	NULL
Cannon	NULL
,	NULL
``	NULL
Marianne	NULL
L.	NULL
Voz	NULL
,	NULL
Michael	NULL
J.	NULL
Pazin	NULL
,	NULL
``	NULL
James	NULL
T.	NULL
Kadonaga	NULL
,	NULL
``	NULL
and	NULL
Katherine	NULL
A.	NULL
Jones'*	NULL
'The	NULL
Salk	NULL
Institute	NULL
for	NULL
Biological	NULL
Studies	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
California	NULL
92037-1099	NULL
USA	NULL
,	NULL
;	NULL
*Department	NULL
of	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
California	NULL
92093-0347	NULL
USA	NULL
Lymphoid	NULL
enhancer-binding	NULL
factor	NULL
1	NULL
(	NULL
LEF-1	NULL
)	NULL
is	NULL
a	NULL
regulatory	NULL
high	NULL
mobility	NULL
group	NULL
(	NULL
HMG	NULL
)	NULL
protein	NULL
that	NULL
activates	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
«	NULL
(	NULL
TCRa	NULL
«	NULL
)	NULL
enhancer	NULL
in	NULL
a	NULL
context-restricted	NULL
manner	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus-1	NULL
(	NULL
HIV-1	NULL
)	NULL
enhancer	NULL
,	NULL
which	NULL
contains	NULL
DNA-binding	NULL
sites	NULL
for	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
,	NULL
also	NULL
provides	NULL
a	NULL
functional	NULL
context	NULL
for	NULL
activation	NULL
by	NULL
LEF-1	NULL
.	NULL

First	NULL
,	NULL
we	NULL
show	NULL
that	NULL
mutations	NULL
in	NULL
the	NULL
LEF-1-binding	NULL
site	NULL
inhibit	NULL
the	NULL
activity	NULL
of	NULL
multimerized	NULL
copies	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
LEF-1/GAL4	NULL
can	NULL
activate	NULL
a	NULL
GAL4-substituted	NULL
HIV-1	NULL
enhancer	NULL
80-	NULL
to	NULL
100-fold	NULL
in	NULL
vivo	NULL
.	NULL

Second	NULL
,	NULL
recombinant	NULL
LEF-1	NULL
is	NULL
shown	NULL
to	NULL
activate	NULL
HIV-1	NULL
transcription	NULL
on	NULL
chromatin-assembled	NULL
DNA	NULL
in	NULL
vitro	NULL
.	NULL

By	NULL
using	NULL
a	NULL
nucleosome-assembly	NULL
system	NULL
derived	NULL
from	NULL
Drosophila	NULL
embryos	NULL
,	NULL
we	NULL
find	NULL
that	NULL
the	NULL
packaging	NULL
of	NULL
DNA	NULL
into	NULL
chromatin	NULL
in	NULL
vitro	NULL
strongly	NULL
represses	NULL
HIV-1	NULL
transcription	NULL
and	NULL
that	NULL
repression	NULL
can	NULL
be	NULL
counteracted	NULL
efficiently	NULL
by	NULL
preincubation	NULL
of	NULL
the	NULL
DNA	NULL
with	NULL
LEF-1	NULL
(	NULL
or	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
)	NULL
supplemented	NULL
with	NULL
fractions	NULL
containing	NULL
the	NULL
promoter-binding	NULL
protein	NULL
,	NULL
Spl	NULL
.	NULL

Addition	NULL
of	NULL
TFE-3	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
an	NULL
E-box	NULL
motif	NULL
upstream	NULL
of	NULL
the	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
sites	NULL
,	NULL
further	NULL
augments	NULL
transcription	NULL
in	NULL
this	NULL
system	NULL
.	NULL

Individually	NULL
or	NULL
collectively	NULL
,	NULL
none	NULL
of	NULL
the	NULL
three	NULL
enhancer-binding	NULL
proteins	NULL
(	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
TFE-3	NULL
)	NULL
could	NULL
activate	NULL
transcription	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Sp1	NULL
.	NULL

A	NULL
truncation	NULL
mutant	NULL
of	NULL
LEF-1	NULL
(	NULL
HMG-88	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
HMG	NULL
box	NULL
but	NULL
lacks	NULL
the	NULL
trans-activation	NULL
domain	NULL
,	NULL
did	NULL
not	NULL
activate	NULL
transcription	NULL
from	NULL
nucleosomal	NULL
DNA	NULL
,	NULL
indicating	NULL
that	NULL
bending	NULL
of	NULL
DNA	NULL
by	NULL
the	NULL
HMG	NULL
domain	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
activate	NULL
transcription	NULL
in	NULL
vitro	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
transcription	NULL
activation	NULL
by	NULL
LEF-1	NULL
in	NULL
vitro	NULL
is	NULL
a	NULL
chromatin-dependent	NULL
process	NULL
that	NULL
requires	NULL
a	NULL
functional	NULL
trans-activation	NULL
domain	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
HMG	NULL
domain	NULL
.	NULL

[	NULL
Key	NULL
Words	NULL
:	NULL
LEF-1	NULL
;	NULL
HMG	NULL
protein	NULL
;	NULL
Ets-1	NULL
;	NULL
HIV-1	NULL
enhancer	NULL
;	NULL
chromatin	NULL
;	NULL
transcription	NULL
]	NULL
Received	NULL
June	NULL
1	NULL
,	NULL
1995	NULL
;	NULL
revised	NULL
version	NULL
accepted	NULL
July	NULL
17	NULL
,	NULL
1995	NULL
.	NULL

The	NULL
assembly	NULL
of	NULL
diverse	NULL
multiprotein	NULL
complexes	NULL
at	NULL
enhancers	NULL
controls	NULL
tissue-specific	NULL
and	NULL
developmental	NULL
stage-appropriate	NULL
regulation	NULL
of	NULL
many	NULL
cellular	NULL
genes	NULL
.	NULL

Viral	NULL
integration	NULL
events	NULL
or	NULL
chromosomal	NULL
translocations	NULL
can	NULL
introduce	NULL
novel	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
to	NULL
genetic	NULL
loci	NULL
or	NULL
,	NULL
alternatively	NULL
,	NULL
position	NULL
new	NULL
genes	NULL
under	NULL
the	NULL
control	NULL
of	NULL
genomic	NULL
enhancers	NULL
.	NULL

Therefore	NULL
,	NULL
viruses	NULL
that	NULL
undergo	NULL
integration	NULL
into	NULL
the	NULL
genome	NULL
as	NULL
a	NULL
mandatory	NULL
step	NULL
in	NULL
their	NULL
replicative	NULL
life	NULL
cycle	NULL
require	NULL
a	NULL
process	NULL
to	NULL
ensure	NULL
active	NULL
transcription	NULL
despite	NULL
wide	NULL
variations	NULL
in	NULL
the	NULL
local	NULL
environment	NULL
of	NULL
the	NULL
integrated	NULL
provirus	NULL
.	NULL

Because	NULL
retroviral	NULL
integration	NULL
occurs	NULL
preferentially	NULL
at	NULL
sites	NULL
in	NULL
nucleosomal	NULL
DNA	NULL
in	NULL
vivo	NULL
(	NULL
Muller	NULL
and	NULL
Varmus	NULL
1994	NULL
)	NULL
,	NULL
the	NULL
virus	NULL
must	NULL
carry	NULL
dominant	NULL
cis-acting	NULL
elements	NULL
that	NULL
establish	NULL
high	NULL
levels	NULL
of	NULL
expression	NULL
from	NULL
promoters	NULL
integrated	NULL
into	NULL
native	NULL
chromatin	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
critical	NULL
to	NULL
understand	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
integrated	NULL
provirus	NULL
and	NULL
the	NULL
mecha-	NULL
*These	NULL
authors	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

*Corresponding	NULL
author	NULL
,	NULL
nisms	NULL
that	NULL
control	NULL
the	NULL
induction	NULL
of	NULL
viral	NULL
transcription	NULL
from	NULL
nucleosomal	NULL
DNA	NULL
.	NULL

Several	NULL
recent	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
control	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus-l1	NULL
(	NULL
HIV-1	NULL
)	NULL
transcription	NULL
from	NULL
the	NULL
integrated	NULL
state	NULL
is	NULL
considerably	NULL
more	NULL
complex	NULL
than	NULL
has	NULL
been	NULL
apparent	NULL
from	NULL
studies	NULL
of	NULL
promoter	NULL
activity	NULL
carried	NULL
out	NULL
using	NULL
transient	NULL
expression	NULL
assays	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
chromatin	NULL
structure	NULL
of	NULL
the	NULL
5	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
of	NULL
integrated	NULL
HIV-1	NULL
genomes	NULL
present	NULL
in	NULL
the	NULL
persistently	NULL
infected	NULL
ACH2	NULL
[	NULL
T	NULL
cell	NULL
)	NULL
and	NULL
UI	NULL
{	NULL
macrophage	NULL
)	NULL
cell	NULL
lines	NULL
by	NULL
nuclease	NULL
hypersensitivity	NULL
and	NULL
fine-structure	NULL
mapping	NULL
suggests	NULL
that	NULL
the	NULL
promoter	NULL
is	NULL
divided	NULL
into	NULL
two	NULL
large	NULL
nucleosome-free	NULL
zones	NULL
(	NULL
-	NULL
255	NULL
to	NULL
-3	NULL
and	NULL
+141	NULL
to	NULL
+265	NULL
)	NULL
,	NULL
each	NULL
of	NULL
which	NULL
span	NULL
several	NULL
distinct	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
(	NULL
Verdin	NULL
1991	NULL
;	NULL
Verdin	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

The	NULL
two	NULL
zones	NULL
are	NULL
separated	NULL
by	NULL
a	NULL
positioned	NULL
nucleosome	NULL
that	NULL
protects	NULL
the	NULL
RNA	NULL
start	NULL
site	NULL
and	NULL
proximal	NULL
downstream	NULL
region	NULL
(	NULL
Verdin	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

Four	NULL
other	NULL
translationally	NULL
positioned	NULL
nucleosomes	NULL
flank	NULL
the	NULL
nucleosome-free	NULL
zones	NULL
.	NULL

The	NULL
positioning	NULL
of	NULL
these	NULL
nucleosomes	NULL
suggests	NULL
that	NULL
the	NULL
2090	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
9	NULL
;	NULL
2090-2104	NULL
G	NULL
1995	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
ISSN	NULL
0890-9369/95	NULL
$	NULL
5.00	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
HIV-1	NULL
enhancer	NULL
is	NULL
controlled	NULL
by	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
within	NULL
a	NULL
relatively	NULL
short	NULL
region	NULL
(	NULL
255	NULL
bp	NULL
)	NULL
upstream	NULL
of	NULL
the	NULL
RNA	NULL
start	NULL
site	NULL
.	NULL

A	NULL
dominant	NULL
nuclease	NULL
hypersensitive	NULL
site	NULL
(	NULL
HSI	NULL
)	NULL
spans	NULL
the	NULL
distal	NULL
region	NULL
of	NULL
this	NULL
enhancer	NULL
(	NULL
-230	NULL
to	NULL
-125	NULL
;	NULL
Verdin	NULL
1991	NULL
)	NULL
and	NULL
includes	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
upstream	NULL
stimulating	NULL
factor	NULL
{	NULL
USF	NULL
}	NULL
{	NULL
and	NULL
other	NULL
members	NULL
of	NULL
the	NULL
class	NULL
B	NULL
family	NULL
of	NULL
E-box-binding	NULL
proteins	NULL
}	NULL
as	NULL
well	NULL
as	NULL
the	NULL
T	NULL
cell-entriched	NULL
proteins	NULL
,	NULL
lymphoid	NULL
enhancer-binding	NULL
factor	NULL
1	NULL
(	NULL
LEF-1	NULL
)	NULL
and	NULL
Ets-1	NULL
(	NULL
{	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Jones	NULL
and	NULL
Peterlin	NULL
1994	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
T	NULL
cells	NULL
induces	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
proximal	NULL
region	NULL
of	NULL
the	NULL
enhancer	NULL
and	NULL
strongly	NULL
up-regulates	NULL
viral	NULL
transcription	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
T	NULL
cell	NULL
activation	NULL
displaces	NULL
or	NULL
disrupts	NULL
the	NULL
positioned	NULL
nucleosome	NULL
near	NULL
the	NULL
RNA	NULL
start	NULL
site	NULL
(	NULL
nuc-1	NULL
)	NULL
,	NULL
and	NULL
creates	NULL
a	NULL
downstream	NULL
extension	NULL
in	NULL
the	NULL
nuclease	NULL
hypersensitive	NULL
site	NULL
within	NULL
the	NULL
promoter	NULL
(	NULL
HSI	NULL
;	NULL
Verdin	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
,	NULL
exposing	NULL
the	NULL
DNA-binding	NULL
site	NULL
for	NULL
the	NULL
ubiquitously	NULL
expressed	NULL
transcription	NULL
factor	NULL
LBP-1	NULL
.	NULL

Disruption	NULL
of	NULL
nuc-1	NULL
is	NULL
postulated	NULL
to	NULL
arise	NULL
as	NULL
a	NULL
result	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
nucleosome	NULL
of	NULL
AP-l-related	NULL
proteins	NULL
(	NULL
El	NULL
Kharroubi	NULL
and	NULL
Verdin	NULL
1994	NULL
)	NULL
,	NULL
which	NULL
are	NULL
strongly	NULL
induced	NULL
upon	NULL
T	NULL
cell	NULL
activation	NULL
;	NULL
however	NULL
,	NULL
the	NULL
significance	NULL
of	NULL
these	NULL
latter	NULL
events	NULL
for	NULL
viral	NULL
transcription	NULL
and	NULL
replication	NULL
is	NULL
not	NULL
yet	NULL
clearly	NULL
understood	NULL
.	NULL

Although	NULL
the	NULL
promoter	NULL
sequences	NULL
that	NULL
are	NULL
necessary	NULL
for	NULL
viral	NULL
gene	NULL
expression	NULL
and	NULL
replication	NULL
have	NULL
not	NULL
been	NULL
defined	NULL
completely	NULL
,	NULL
a	NULL
recent	NULL
report	NULL
suggests	NULL
that	NULL
the	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
is	NULL
particularly	NULL
important	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
integrated	NULL
HIV-1	NULL
proviral	NULL
promoter	NULL
in	NULL
T	NULL
cell	NULL
lines	NULL
(	NULL
Kim	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
viruses	NULL
containing	NULL
a	NULL
linker-scanning	NULL
mutation	NULL
from	NULL
-130	NULL
to	NULL
-147	NULL
,	NULL
which	NULL
alters	NULL
the	NULL
DNA-binding	NULL
sites	NULL
for	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
,	NULL
were	NULL
found	NULL
to	NULL
be	NULL
defective	NULL
for	NULL
virus	NULL
replication	NULL
in	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
or	NULL
in	NULL
the	NULL
11.8	NULL
(	NULL
T	NULL
)	NULL
cell	NULL
line	NULL
and	NULL
also	NULL
displayed	NULL
delayed	NULL
replication	NULL
kinetics	NULL
in	NULL
an	NULL
immature	NULL
T	NULL
cell	NULL
(	NULL
CEM	NULL
)	NULL
line	NULL
(	NULL
Kim	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

Several	NULL
other	NULL
mutations	NULL
in	NULL
the	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
enhancer	NULL
generated	NULL
similar	NULL
``	NULL
replication-defective	NULL
``	NULL
phe-notypes	NULL
.	NULL

Because	NULL
the	NULL
mutant	NULL
viruses	NULL
were	NULL
not	NULL
affected	NULL
for	NULL
viral	NULL
entry	NULL
or	NULL
integration	NULL
,	NULL
the	NULL
defects	NULL
were	NULL
attributed	NULL
to	NULL
problems	NULL
with	NULL
proviral	NULL
transcription	NULL
.	NULL

Despite	NULL
the	NULL
dramatic	NULL
effects	NULL
of	NULL
distal	NULL
enhancer	NULL
mutations	NULL
on	NULL
virus	NULL
rep-lication	NULL
,	NULL
however	NULL
,	NULL
these	NULL
same	NULL
mutations	NULL
have	NULL
only	NULL
modest	NULL
effects	NULL
on	NULL
HIV-1	NULL
promoter	NULL
activity	NULL
in	NULL
transient	NULL
expression	NULL
assays	NULL
or	NULL
in	NULL
vitro	NULL
transcription	NULL
experiments	NULL
(	NULL
Zeichner	NULL
et	NULL
al	NULL
.	NULL

1991	NULL
a	NULL
,	NULL
b	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
may	NULL
be	NULL
considerably	NULL
more	NULL
important	NULL
for	NULL
promoters	NULL
assembled	NULL
into	NULL
physiological	NULL
chromatin	NULL
,	NULL
as	NULL
occurs	NULL
upon	NULL
stable	NULL
integration	NULL
of	NULL
the	NULL
virus	NULL
,	NULL
than	NULL
it	NULL
is	NULL
for	NULL
promoter	NULL
activity	NULL
on	NULL
transfected	NULL
plasmid	NULL
DNAs	NULL
.	NULL

The	NULL
prospect	NULL
that	NULL
the	NULL
LEF-1	NULL
high	NULL
mobility	NULL
group	NULL
(	NULL
HMG	NULL
)	NULL
protein	NULL
might	NULL
regulate	NULL
HIV-1	NULL
transcription	NULL
was	NULL
intriguing	NULL
because	NULL
to	NULL
date	NULL
the	NULL
only	NULL
defined	NULL
target	NULL
for	NULL
LEF-1	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
the	NULL
minimal	NULL
enhancer	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
«	NULL
[	NULL
TCRo	NULL
)	NULL
chain	NULL
gene	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Clevers	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
;	NULL
Grossched	NULL
]	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
)	NULL
.	NULL

Studies	NULL
with	NULL
the	NULL
TCRa	NULL
enhancer	NULL
have	NULL
suggested	NULL
that	NULL
LEF-1	NULL
activity	NULL
is	NULL
strongly	NULL
influenced	NULL
by	NULL
the	NULL
positioning	NULL
of	NULL
its	NULL
binding	NULL
site	NULL
relative	NULL
Chromatin-dependent	NULL
trans-activation	NULL
by	NULL
LEF-1	NULL
to	NULL
sites	NULL
for	NULL
other	NULL
enhancer	NULL
proteins	NULL
,	NULL
including	NULL
Ets-1	NULL
(	NULL
Waterman	NULL
and	NULL
Jones	NULL
1990	NULL
;	NULL
Travis	NULL
et	NULL
al	NULL
.	NULL

1991	NULL
;	NULL
Waterman	NULL
et	NULL
al	NULL
.	NULL

1991	NULL
)	NULL
.	NULL

LEF-1	NULL
binds	NULL
DNA	NULL
as	NULL
a	NULL
monomer	NULL
through	NULL
a	NULL
single	NULL
HMG	NULL
box	NULL
(	NULL
Travis	NULL
et	NULL
al	NULL
.	NULL

1991	NULL
;	NULL
Waterman	NULL
et	NULL
al	NULL
.	NULL

1991	NULL
;	NULL
Carlsson	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
,	NULL
and	NULL
bends	NULL
DNA	NULL
strongly	NULL
in	NULL
vitro	NULL
(	NULL
Giese	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
LEF-1	NULL
may	NULL
behave	NULL
as	NULL
an	NULL
architectural	NULL
transcription	NULL
factor	NULL
and	NULL
function	NULL
indirectly	NULL
through	NULL
bending	NULL
of	NULL
the	NULL
DNA	NULL
to	NULL
promote	NULL
interactions	NULL
between	NULL
other	NULL
enhancer-binding	NULL
proteins	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
;	NULL
Tjian	NULL
and	NULL
Maniatis	NULL
1994	NULL
)	NULL
,	NULL
transient	NULL
expression	NULL
assays	NULL
have	NULL
shown	NULL
that	NULL
LEF-1	NULL
activity	NULL
in	NULL
vivo	NULL
strongly	NULL
depends	NULL
on	NULL
sequences	NULL
that	NULL
lie	NULL
outside	NULL
of	NULL
the	NULL
HMG	NULL
domain	NULL
(	NULL
Carlsson	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
fusion	NULL
of	NULL
the	NULL
LEF-1	NULL
amino-terminal	NULL
trans-activation	NULL
domain	NULL
to	NULL
a	NULL
heterologous	NULL
DNA-binding	NULL
domain	NULL
(	NULL
GAL4	NULL
or	NULL
LexA	NULL
)	NULL
generates	NULL
a	NULL
chimeric	NULL
activator	NULL
that	NULL
strongly	NULL
induces	NULL
the	NULL
TCRa	NULL
«	NULL
enhancer	NULL
in	NULL
T	NULL
cells	NULL
without	NULL
significant	NULL
bending	NULL
of	NULL
the	NULL
DNA	NULL
(	NULL
Carlsson	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
;	NULL
Giese	NULL
and	NULL
Grosschedl	NULL
1993	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
suggest	NULL
that	NULL
bending	NULL
of	NULL
the	NULL
DNA	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
activate	NULL
transcription	NULL
and	NULL
that	NULL
LEF-1	NULL
must	NULL
play	NULL
a	NULL
more	NULL
direct	NULL
role	NULL
in	NULL
transcriptional	NULL
activation	NULL
or	NULL
in	NULL
the	NULL
assembly	NULL
of	NULL
a	NULL
stereospecific	NULL
multiprotein	NULL
complex	NULL
at	NULL
the	NULL
enhancer	NULL
.	NULL

To	NULL
better	NULL
understand	NULL
the	NULL
selective	NULL
activity	NULL
of	NULL
LEF-1	NULL
in	NULL
T	NULL
cells	NULL
it	NULL
will	NULL
be	NULL
critical	NULL
to	NULL
define	NULL
and	NULL
characterize	NULL
other	NULL
LEF-responsive	NULL
enhancers	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
tested	NULL
the	NULL
premise	NULL
that	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
is	NULL
regulated	NULL
by	NULL
LEF-1	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
.	NULL

First	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
LEF-1	NULL
activates	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

With	NULL
the	NULL
intention	NULL
of	NULL
developing	NULL
a	NULL
general	NULL
in	NULL
vitro	NULL
model	NULL
that	NULL
can	NULL
be	NULL
used	NULL
to	NULL
study	NULL
transcriptional	NULL
activation	NULL
from	NULL
the	NULL
integrated	NULL
HIV-1	NULL
provirus	NULL
,	NULL
we	NULL
next	NULL
analyzed	NULL
the	NULL
ability	NULL
of	NULL
recombinant	NULL
LEF-1	NULL
and	NULL
other	NULL
enhancer-binding	NULL
proteins	NULL
to	NULL
induce	NULL
viral	NULL
transcription	NULL
from	NULL
DNA	NULL
packaged	NULL
into	NULL
chromatin	NULL
by	NULL
incubation	NULL
with	NULL
Drosophila	NULL
nucleosome	NULL
assembly	NULL
extracts	NULL
.	NULL

The	NULL
results	NULL
reveal	NULL
that	NULL
LEF-1	NULL
and	NULL
other	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
effectively	NULL
counteract	NULL
nucleosomal	NULL
repression	NULL
of	NULL
HIV-1	NULL
transcription	NULL
in	NULL
vitro	NULL
.	NULL

Interestingly	NULL
,	NULL
LEF-1	NULL
was	NULL
unable	NULL
to	NULL
stimulate	NULL
RNA	NULL
synthesis	NULL
from	NULL
naked	NULL
DNA	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
may	NULL
play	NULL
a	NULL
chromatin-dependent	NULL
role	NULL
in	NULL
transcription	NULL
.	NULL

We	NULL
-	NULL
also	NULL
demonstrate	NULL
that	NULL
nucleosomal	NULL
derepression	NULL
by	NULL
LEF-1	NULL
requires	NULL
the	NULL
amino-terminal	NULL
trans-activation	NULL
domain	NULL
and	NULL
is	NULL
not	NULL
the	NULL
simple	NULL
consequence	NULL
of	NULL
bending	NULL
or	NULL
wrapping	NULL
of	NULL
DNA	NULL
by	NULL
the	NULL
HMG	NULL
domain	NULL
.	NULL

Our	NULL
results	NULL
provide	NULL
a	NULL
highly	NULL
sensitive	NULL
biochemical	NULL
assay	NULL
that	NULL
can	NULL
be	NULL
used	NULL
to	NULL
study	NULL
the	NULL
mechanism	NULL
of	NULL
activation	NULL
by	NULL
LEF-1	NULL
as	NULL
well	NULL
as	NULL
model	NULL
the	NULL
events	NULL
leading	NULL
to	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
integrated	NULL
HIV-1	NULL
provirus	NULL
.	NULL

Results	NULL
The	NULL
distal	NULL
HIV-1	NULL
enhancer	NULL
provides	NULL
a	NULL
functional	NULL
context	NULL
for	NULL
activation	NULL
by	NULL
LEF-1	NULL
in	NULL
vivo	NULL
Previously	NULL
we	NULL
reported	NULL
that	NULL
LEF-1	NULL
protein	NULL
purified	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
binds	NULL
to	NULL
three	NULL
sites	NULL
in	NULL
the	NULL
HIV-1	NULL
promoter	NULL
,	NULL
with	NULL
the	NULL
highest-affinity	NULL
site	NULL
(	NULL
-	NULL
121	NULL
to	NULL
-142	NULL
)	NULL
located	NULL
in	NULL
the	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
enhancer	NULL
(	NULL
Waterman	NULL
and	NULL
Jones	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
2091	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Sheridan	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
Jurkat	NULL
nuclear	NULL
proteins	NULL
to	NULL
this	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
reveals	NULL
a	NULL
continuous	NULL
pattern	NULL
of	NULL
protection	NULL
covering	NULL
the	NULL
region	NULL
from	NULL
-121	NULL
to	NULL
-177	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Only	NULL
a	NULL
portion	NULL
of	NULL
this	NULL
region	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
E-box	NULL
motif	NULL
,	NULL
is	NULL
recognized	NULL
by	NULL
proteins	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
8,9	NULL
)	NULL
.	NULL

The	NULL
E-box	NULL
is	NULL
bound	NULL
by	NULL
USF	NULL
and	NULL
related	NULL
members	NULL
of	NULL
the	NULL
helix-loop-helix	NULL
family	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
,	NULL
including	NULL
TFE-3	NULL
.	NULL

Upon	NULL
inspection	NULL
of	NULL
the	NULL
sequences	NULL
between	NULL
the	NULL
LEF-1-binding	NULL
site	NULL
and	NULL
the	NULL
E-box	NULL
motif	NULL
we	NULL
discovered	NULL
a	NULL
potential	NULL
binding	NULL
site	NULL
for	NULL
Ets-1	NULL
(	NULL
-	NULL
140	NULL
and	NULL
-	NULL
160	NULL
}	NULL
,	NULL
which	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
Ets-1	NULL
binds	NULL
in	NULL
conjunction	NULL
with	NULL
LEF-1	NULL
to	NULL
create	NULL
the	NULL
lymphoid-specific	NULL
footprint	NULL
observed	NULL
in	NULL
extracts	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
purified	NULL
recombinant	NULL
enhancer	NULL
proteins	NULL
(	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
confirmed	NULL
that	NULL
Ets-1	NULL
can	NULL
bind	NULL
together	NULL
with	NULL
LEF-1	NULL
and	NULL
TFE-3	NULL
to	NULL
the	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
enhancer	NULL
.	NULL

Recombinant	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
TFE-3	NULL
proteins	NULL
generate	NULL
overlapping	NULL
footprints	NULL
on	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
,	NULL
and	NULL
all	NULL
three	NULL
proteins	NULL
added	NULL
together	NULL
recreate	NULL
the	NULL
footprint	NULL
that	NULL
is	NULL
observed	NULL
in	NULL
Jurkat	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
6,7	NULL
)	NULL
.	NULL

Competition	NULL
studies	NULL
confirmed	NULL
that	NULL
this	NULL
extended	NULL
footprint	NULL
contains	NULL
tandem	NULL
binding	NULL
sites	NULL
for	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
USF/TFE-3	NULL
,	NULL
and	NULL
gel	NULL
shift	NULL
experiments	NULL
suggest	NULL
that	NULL
Ets-l	NULL
binds	NULL
cooperatively	NULL
with	NULL
E-box	NULL
proteins	NULL
in	NULL
nuclear	NULL
extracts	NULL
[	NULL
(	NULL
M.	NULL
Voz	NULL
and	NULL
C.	NULL
Sheline	NULL
,	NULL
unpubl	NULL
.	NULL
)	NULL

.	NULL

Thus	NULL
,	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
USF/TFE-3	NULL
A	NULL
bind	NULL
synergistically	NULL
to	NULL
a	NULL
region	NULL
located	NULL
25	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
.	NULL

To	NULL
test	NULL
the	NULL
possibility	NULL
that	NULL
LEF-1	NULL
can	NULL
regulate	NULL
HIV-1	NULL
enhancer	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
region	NULL
between	NULL
-81	NULL
and	NULL
-177	NULL
containing	NULL
the	NULL
NF-KB	NULL
,	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
USF/TFE-3-binding	NULL
sites	NULL
was	NULL
isolated	NULL
and	NULL
cloned	NULL
in	NULL
tandem	NULL
copies	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
herpes	NULL
simplex	NULL
virus-1	NULL
(	NULL
HSV-1	NULL
)	NULL
thymidine	NULL
kinase	NULL
(	NULL
tk	NULL
)	NULL
promoter	NULL
and	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

Site-specific	NULL
mutants	NULL
were	NULL
generated	NULL
in	NULL
the	NULL
enhancer	NULL
to	NULL
disrupt	NULL
the	NULL
individual	NULL
binding	NULL
sites	NULL
for	NULL
NF-kB	NULL
,	NULL
LEF-1	NULL
,	NULL
and	NULL
Ets-1	NULL
,	NULL
and	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
various	NULL
constructs	NULL
were	NULL
assessed	NULL
by	NULL
transfection	NULL
into	NULL
phorbol	NULL
ester	NULL
(	NULL
TPA	NULL
)	NULL
-treated	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

A	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
generated	NULL
relatively	NULL
low	NULL
activity	NULL
in	NULL
vivo	NULL
,	NULL
whereas	NULL
the	NULL
duplicated	NULL
enhancer	NULL
was	NULL
quite	NULL
active	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
NF-kB	NULL
repeats	NULL
strongly	NULL
inhibited	NULL
HIV-1	NULL
enhancer	NULL
activity	NULL
;	NULL
however	NULL
,	NULL
mutations	NULL
in	NULL
the	NULL
LEF-1-	NULL
and	NULL
Ets-l-binding	NULL
sites	NULL
were	NULL
also	NULL
quite	NULL
detrimental	NULL
to	NULL
enhancer	NULL
function	NULL
under	NULL
these	NULL
conditions	NULL
,	NULL
reducing	NULL
activity	NULL
to	NULL
10	NULL
%	NULL
-15	NULL
%	NULL
of	NULL
that	NULL
seen	NULL
with	NULL
the	NULL
wild-type	NULL
HIV-1	NULL
enhancer	NULL
.	NULL

A	NULL
deletion	NULL
mutant	NULL
affecting	NULL
the	NULL
USF/TFE-3-binding	NULL
site	NULL
{	NULL
(	NULL
AE	NULL
)	NULL
reduced	NULL
enhancer	NULL
activity	NULL
approximately	NULL
threefold	NULL
in	NULL
vivo	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
LEF-1-	NULL
and	NULL
Ets-l-binding	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
optimal	NULL
HIV-1	NULL
enhancer	NULL
activity	NULL
in	NULL
activated	NULL
Jurkat	NULL
{	NULL
T	NULL
)	NULL
cells	NULL
.	NULL

_L	NULL
-	NULL
>	NULL
B	NULL
Figure	NULL
1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Analysis	NULL
of	NULL
proteins	NULL
>	NULL
E-BOX	NULL
%	NULL
s	NULL
[	NULL
=	NULL
--	NULL
ua	NULL
@	NULL
:	NULL
bound	NULL
to	NULL
the	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
(	NULL
-121	NULL
to	NULL
-177	NULL
)	NULL
in	NULL
DNase	NULL
I	NULL
footprint	NULL
experiments	NULL
.	NULL

Brackets	NULL
indi-	NULL
(	NULL
se	NULL
tee	NULL
ure	NULL
mae	NULL
wa	NULL
_	NULL
&	NULL
&	NULL
erat	NULL
saves	NULL
ween	NULL
&	NULL
C	NULL
C	NULL
&	NULL
we	NULL
«	NULL
«	NULL
-	NULL
®	NULL
``	NULL
|	NULL
am	NULL
Mr	NULL
(	NULL
go	NULL
a	NULL
(	NULL
$	NULL
9	NULL
«	NULL
(	NULL
go	NULL
=	NULL
tas	NULL
wat	NULL
*/*	NULL
ta	NULL
ae	NULL
as	NULL
200	NULL
wu	NULL
Shee	NULL
Slit	NULL
=	NULL
>	NULL
98	NULL
``	NULL
cate	NULL
the	NULL
binding	NULL
sites	NULL
observed	NULL
for	NULL
the	NULL
i	NULL
ﬂ	NULL
d	NULL
salt	NULL
L	NULL
purified	NULL
recombinant	NULL
enhancer-binding	NULL
LEF	NULL
|	NULL
@	NULL
a	NULL
;	NULL
*	NULL
m	NULL
x	NULL
-	NULL
w	NULL
``	NULL
as	NULL
-	NULL
@	NULL
@	NULL
»	NULL
-~	NULL
proteins	NULL
,	NULL
LEF-1	NULL
{	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
Ets-1	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
fee	NULL
.	NULL

!	NULL

!	NULL

us	NULL
#	NULL
s	NULL
~~	NULL
-*	NULL
ze	NULL
-	NULL
-	NULL
>	NULL
TFE-3	NULL
{	NULL
lane	NULL
4	NULL
}	NULL
,	NULL
TFE-3	NULL
and	NULL
Ets-1	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
WB	NULL
u	NULL
»	NULL
ust	NULL
WB	NULL
was	NULL
was	NULL
oo	NULL
<	NULL
+	NULL
2s	NULL
tms	NULL
and	NULL
for	NULL
a	NULL
mixture	NULL
of	NULL
all	NULL
three	NULL
proteins	NULL
wag	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

The	NULL
DNase	NULL
I	NULL
footprint	NULL
patterns	NULL
~	NULL
ag	NULL
z	NULL
“	NULL
:	NULL
wa	NULL
tk	NULL
«	NULL
.-	NULL
ESR	NULL
generated	NULL
using	NULL
crude	NULL
nuclear	NULL
extracts	NULL
ETE	NULL
:	NULL
from	NULL
Jurkat	NULL
(	NULL
T	NULL
)	NULL
cells	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
from	NULL
the	NULL
-	NULL
EB	NULL
a	NULL
.	NULL

§2	NULL
as	NULL
is	NULL
to	NULL
e	NULL
wo	NULL
15	NULL
|	NULL
e®	NULL
tes	NULL
nonlymphoid	NULL
cell	NULL
lines	NULL
Tub	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
or	NULL
f	NULL
HeLa	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
are	NULL
shown	NULL
for	NULL
compari-	NULL
#	NULL
s	NULL
;	NULL
Sp1	NULL
son	NULL
.	NULL

The	NULL
control	NULL
digestion	NULL
pattern	NULL
ob-	NULL
==	NULL
us	NULL
uo	NULL
po	NULL
w=	NULL
ys	NULL
served	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA-binding	NULL
ms	NULL
as	NULL
proteins	NULL
is	NULL
shown	NULL
in	NULL
lanes	NULL
1	NULL
and	NULL
10	NULL
.	NULL

(	NULL
B	NULL
)	NULL
wit	NULL
Sut	NULL
Seme	NULL
mune	NULL
mse	NULL
SDS-PAGE	NULL
analysis	NULL
of	NULL
purified	NULL
recom-	NULL
#	NULL
``	NULL
fs	NULL
[	NULL
binant	NULL
proteins	NULL
.	NULL

LEF-1	NULL
and	NULL
HMG-88	NULL
were	NULL
expressed	NULL
as	NULL
fusion	NULL
proteins	NULL
with	NULL
a	NULL
short	NULL
region	NULL
of	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
the	NULL
bacterial	NULL
gene-10	NULL
protein	NULL
,	NULL
Ets-1	NULL
was	NULL
expressed	NULL
and	NULL
purified	NULL
as	NULL
a	NULL
GST	NULL
fusion	NULL
protein	NULL
,	NULL
and	NULL
TFE-3	NULL
was	NULL
expressed	NULL
as	NULL
a	NULL
native	NULL
(	NULL
nonfusion	NULL
)	NULL
protein	NULL
{	NULL
see	NULL
Materials	NULL
and	NULL
methods	NULL
)	NULL
.	NULL

Aliquots	NULL
containing	NULL
300-600	NULL
ng	NULL
aliquots	NULL
of	NULL
each	NULL
protein	NULL
fraction	NULL
were	NULL
loaded	NULL
onto	NULL
discontinuous	NULL
12	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
visualized	NULL
by	NULL
Coomassie	NULL
staining	NULL
;	NULL
molecular	NULL
size	NULL
standards	NULL
(	NULL
Mr	NULL
)	NULL
are	NULL
indicated	NULL
at	NULL
left	NULL
.	NULL

-177	NULL
2092	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
Ebox	NULL
Ets	NULL
LEF	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
TAR	NULL
(	NULL
NFB	NULL
)	NULL
Sp1	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Chromatin-dependent	NULL
trans-activation	NULL
by	NULL
LEF-1	NULL
E-box	NULL
ETS	NULL
LEF	NULL
NF-	NULL
«	NULL
B	NULL
E-box	NULL
ETS	NULL
NF-	NULL
«	NULL
B	NULL
CXS	NULL
{	NULL
u	NULL
``	NULL
CSI	NULL
GAL	NULL
GD	NULL
tata	NULL
{	NULL
tug	NULL
177	NULL
-81	NULL
177	NULL
-81	NULL
6,000,000	NULL
X	NULL
400,000	NULL
-	NULL
az	NULL
5,000,000	NULL
>	NULL
4,000,000	NULL
_	NULL
-	NULL
8000004	NULL
13	NULL
.2	NULL
®	NULL
2,000,000	NULL
8	NULL
a	NULL
Pr	NULL
®	NULL
&	NULL
s	NULL
o	NULL
&	NULL
©	NULL
_	NULL
200,000	NULL
2	NULL
2	NULL
a	NULL
C	NULL
8	NULL
=	NULL
2,000,000	NULL
we	NULL
$	NULL
®	NULL
o	NULL
p	NULL
S	NULL
&	NULL
og	NULL
&	NULL
3	NULL
o	NULL
«	NULL
©	NULL
+1	NULL
CQ	NULL
3	NULL
o	NULL
a	NULL
f	NULL
a	NULL
®	NULL
-A	NULL
)	NULL
c	NULL
+H	NULL
1,000,000	NULL
a	NULL
2	NULL
5	NULL
N	NULL
ip	NULL
100,000	NULL
|	NULL
0	NULL
>	NULL
ox	NULL
60	NULL
a	NULL
r	NULL
a	NULL
g	NULL
``	NULL
il	NULL
gpo	NULL
uu	NULL
o	NULL
-	NULL
q	NULL
&	NULL
44	NULL
C	NULL
;	NULL
hLEF/GAL4	NULL
:	NULL
-	NULL
+	NULL
-	NULL
+	NULL
tog	NULL
-	NULL
t	NULL
-	NULL
+	NULL
Z	NULL
.	NULL

|-	NULL
i	NULL
i	NULL
1	NULL
i	NULL
i	NULL
_	NULL
i	NULL
A	NULL
L0	NULL
Lu	NULL
--	NULL
2	NULL
X	NULL
enh	NULL
--	NULL
WT	NULL
-	NULL
NF-	NULL
«	NULL
B	NULL
-	NULL
WT	NULL
-	NULL
ETS	NULL
_	NULL
AE-Figure	NULL
2	NULL
.	NULL

{	NULL
(	NULL
A	NULL
)	NULL
Transient	NULL
expression	NULL
analysis	NULL
of	NULL
HIV-1/LUC	NULL
constructs	NULL
containing	NULL
one	NULL
or	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
(	NULL
-	NULL
81	NULL
to	NULL
-	NULL
177	NULL
)	NULL
upstream	NULL
of	NULL
the	NULL
HSV	NULL
tk	NULL
promoter	NULL
and	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

Constructs	NULL
were	NULL
transfected	NULL
into	NULL
activated	NULL
Jurkat	NULL
(	NULL
T	NULL
)	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
to	NULL
a	NULL
pCMV/CAT	NULL
plasmid	NULL
added	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

The	NULL
relative	NULL
activities	NULL
of	NULL
constructs	NULL
containing	NULL
site-specific	NULL
mutations	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
or	NULL
E-box	NULL
motifs	NULL
,	NULL
are	NULL
indicated	NULL
in	NULL
the	NULL
diagram	NULL
.	NULL

The	NULL
bars	NULL
show	NULL
the	NULL
results	NULL
from	NULL
a	NULL
single	NULL
representative	NULL
transfection	NULL
experiment	NULL
,	NULL
and	NULL
the	NULL
average	NULL
values	NULL
obtained	NULL
from	NULL
three	NULL
independent	NULL
transfections	NULL
are	NULL
indicated	NULL
by	NULL
percentages	NULL
listed	NULL
above	NULL
the	NULL
bars	NULL
.	NULL

[	NULL
B	NULL
)	NULL
Induction	NULL
of	NULL
a	NULL
GAL4-substituted	NULL
HIV-1	NULL
enhancer	NULL
by	NULL
LEF-1/GAL4	NULL
in	NULL
activated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
distal	NULL
LEF-1-binding	NULL
site	NULL
in	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
was	NULL
replaced	NULL
by	NULL
the	NULL
DNA-binding	NULL
site	NULL
for	NULL
GAL4	NULL
as	NULL
indicated	NULL
schematically	NULL
at	NULL
the	NULL
top	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
the	NULL
wild-type	NULL
{	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
mutant	NULL
DNAs	NULL
by	NULL
LEF-1/GAL4	NULL
seen	NULL
in	NULL
a	NULL
single	NULL
representative	NULL
transfection	NULL
are	NULL
shown	NULL
in	NULL
the	NULL
graph	NULL
,	NULL
and	NULL
the	NULL
numbers	NULL
above	NULL
the	NULL
bars	NULL
indicate	NULL
the	NULL
average	NULL
fold	NULL
induction	NULL
by	NULL
LEF-1/GAL4	NULL
observed	NULL
in	NULL
three	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

Luciferase	NULL
activity	NULL
(	NULL
vertical	NULL
axis	NULL
)	NULL
was	NULL
normalized	NULL
to	NULL
a	NULL
pCMV/CAT	NULL
reporter	NULL
gene	NULL
that	NULL
had	NULL
been	NULL
included	NULL
as	NULL
a	NULL
control	NULL
in	NULL
each	NULL
transfection	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
cloned	NULL
LEF-1	NULL
protein	NULL
is	NULL
capable	NULL
of	NULL
activating	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
,	NULL
the	NULL
HIV-1	NULL
LEF-1	NULL
site	NULL
was	NULL
replaced	NULL
with	NULL
the	NULL
DNA-binding	NULL
site	NULL
for	NULL
the	NULL
yeast	NULL
GAL4	NULL
activator	NULL
,	NULL
and	NULL
this	NULL
construct	NULL
was	NULL
tested	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
respond	NULL
in	NULL
vivo	NULL
to	NULL
LEF-1/GAL4	NULL
,	NULL
a	NULL
chimeric	NULL
protein	NULL
that	NULL
contains	NULL
the	NULL
LEF-1	NULL
trans-activation	NULL
domain	NULL
{	NULL
amino	NULL
acids	NULL
80-256	NULL
)	NULL
fused	NULL
to	NULL
the	NULL
DNA-binding	NULL
domain	NULL
{	NULL
(	NULL
amino	NULL
acids	NULL
1-147	NULL
)	NULL
of	NULL
GAL4	NULL
(	NULL
Carlsson	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

We	NULL
showed	NULL
previously	NULL
that	NULL
LEF-1/GAL4	NULL
can	NULL
activate	NULL
a	NULL
GAL4-substituted	NULL
TCRa	NULL
enhancer	NULL
20-	NULL
to	NULL
40-fold	NULL
upon	NULL
transfection	NULL
into	NULL
activated	NULL
Jurkat	NULL
cells	NULL
(	NULL
Carlsson	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

Like	NULL
the	NULL
native	NULL
LEF-1	NULL
protein	NULL
,	NULL
the	NULL
LEF-1/GAL4	NULL
protein	NULL
could	NULL
activate	NULL
the	NULL
TCRa	NULL
enhancer	NULL
but	NULL
not	NULL
other	NULL
promoters	NULL
containing	NULL
only	NULL
reiterated	NULL
GAL4	NULL
DNA-binding	NULL
sites	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
2B	NULL
,	NULL
the	NULL
GAL4-substituted	NULL
HIV-1	NULL
enhancer	NULL
was	NULL
strongly	NULL
induced	NULL
(	NULL
80-	NULL
to	NULL
100-fold	NULL
)	NULL
by	NULL
LEF-1/GALA4	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
induced	NULL
less	NULL
than	NULL
twofold	NULL
by	NULL
the	NULL
GAL4	NULL
DNA-binding	NULL
do	NULL
main	NULL
alone	NULL
[	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
a	NULL
comparison	NULL
of	NULL
trun-cation	NULL
,	NULL
and	NULL
amino	NULL
acid	NULL
substitution	NULL
mutants	NULL
in	NULL
the	NULL
LEF-1	NULL
activation	NULL
domain	NULL
indicated	NULL
that	NULL
the	NULL
same	NULL
regions	NULL
of	NULL
the	NULL
trans-activation	NULL
domain	NULL
are	NULL
required	NULL
to	NULL
activate	NULL
the	NULL
HIV-1	NULL
and	NULL
TCRa	NULL
enhancers	NULL
in	NULL
vivo	NULL
{	NULL
T.P	NULL
,	NULL
Mayall	NULL
and	NULL
K.	NULL
Jones	NULL
,	NULL
unpubl	NULL
.	NULL
)	NULL

.	NULL

Mutation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
in	NULL
the	NULL
GAL4-substituted	NULL
enhancer	NULL
greatly	NULL
diminished	NULL
basal	NULL
activity	NULL
of	NULL
these	NULL
constructs	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
function	NULL
independently	NULL
of	NULL
other	NULL
factors	NULL
,	NULL
but	NULL
still	NULL
supported	NULL
partial	NULL
activation	NULL
by	NULL
LEF-1/	NULL
GALA	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutations	NULL
in	NULL
the	NULL
Ets-1	NULL
and	NULL
E-box	NULL
motifs	NULL
did	NULL
not	NULL
affect	NULL
transcription	NULL
of	NULL
the	NULL
GAL4-substituted	NULL
enhancer	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
LEF-1/GAL4	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
these	NULL
elements	NULL
requires	NULL
an	NULL
intact	NULL
LEF-1-binding	NULL
site	NULL
.	NULL

The	NULL
mutation	NULL
affecting	NULL
the	NULL
Ets-1	NULL
DNA-binding	NULL
site	NULL
reduced	NULL
activation	NULL
most	NULL
severely	NULL
by	NULL
LEF-1/GAL4	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
studies	NULL
indicate	NULL
that	NULL
the	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
distal	NULL
domain	NULL
of	NULL
the	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
2093	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Sheridan	NULL
et	NULL
al	NULL
.	NULL

HIV-1	NULL
enhancer	NULL
provide	NULL
a	NULL
functional	NULL
context	NULL
for	NULL
activation	NULL
by	NULL
LEF-1	NULL
in	NULL
vivo	NULL
.	NULL

LEF-1	NULL
and	NULL
Ets-1	NULL
act	NULL
with	NULL
Sp1	NULL
to	NULL
stimulate	NULL
HIV-1	NULL
transcription	NULL
on	NULL
chromatin-assembled	NULL
DNA	NULL
in	NULL
vitro	NULL
Although	NULL
LEF-1	NULL
can	NULL
activate	NULL
the	NULL
minimal	NULL
HIV-1	NULL
enhancer	NULL
in	NULL
transient	NULL
expression	NULL
assays	NULL
,	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
mutant	NULL
virus	NULL
(	NULL
Kim	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
suggest	NULL
that	NULL
LEF-1	NULL
might	NULL
have	NULL
a	NULL
more	NULL
profound	NULL
effect	NULL
on	NULL
viral	NULL
transcription	NULL
from	NULL
proviral	NULL
promoters	NULL
integrated	NULL
into	NULL
nucleosomal	NULL
DNA	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
a	NULL
series	NULL
of	NULL
experiments	NULL
to	NULL
determine	NULL
whether	NULL
recombinant	NULL
LEF-1	NULL
can	NULL
activate	NULL
HIV-1	NULL
transcription	NULL
in	NULL
vitro	NULL
from	NULL
nu-cleosome-reconstituted	NULL
DNA	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
the	NULL
pHIV-1/LUC	NULL
DNA	NULL
templates	NULL
were	NULL
incubated	NULL
with	NULL
Drosophila	NULL
embryo	NULL
extracts	NULL
that	NULL
are	NULL
capable	NULL
of	NULL
efficiently	NULL
reconstituting	NULL
nucleosomes	NULL
when	NULL
supplemented	NULL
with	NULL
purified	NULL
core	NULL
histones	NULL
,	NULL
histone	NULL
H1	NULL
,	NULL
and	NULL
an	NULL
ATP-regenerating	NULL
system	NULL
[	NULL
Kamakaka	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
;	NULL
Bulger	NULL
and	NULL
Kadonaga	NULL
1994	NULL
)	NULL
.	NULL

Micrococcal	NULL
nuclease	NULL
(	NULL
MNase	NULL
)	NULL
digestion	NULL
of	NULL
the	NULL
reconstituted	NULL
HIV-1	NULL
chromatin	NULL
revealed	NULL
a	NULL
long	NULL
periodic	NULL
array	NULL
of	NULL
nucleosomes	NULL
similar	NULL
to	NULL
that	NULL
found	NULL
in	NULL
physiological	NULL
chromatin	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
ability	NULL
of	NULL
recombinant	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
TFE-3	NULL
proteins	NULL
to	NULL
stimulate	NULL
transcription	NULL
from	NULL
the	NULL
chromatin-assembled	NULL
HIV-1	NULL
enhancer	NULL
,	NULL
the	NULL
purified	NULL
proteins	NULL
were	NULL
preincubated	NULL
in	NULL
different	NULL
combinations	NULL
with	NULL
the	NULL
DNA	NULL
prior	NULL
to	NULL
nucleosome	NULL
assembly	NULL
,	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
schematic	NULL
diagram	NULL
shown	NULL
in	NULL
Figure	NULL
3A	NULL
.	NULL

Following	NULL
nucleosome	NULL
assembly	NULL
,	NULL
HeLa	NULL
nuclear	NULL
transcription	NULL
extract	NULL
was	NULL
added	NULL
together	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
«	NULL
-globin	NULL
gene	NULL
,	NULL
and	NULL
pre-initiation	NULL
complexes	NULL
were	NULL
allowed	NULL
to	NULL
form	NULL
for	NULL
20	NULL
min	NULL
prior	NULL
to	NULL
transcription	NULL
.	NULL

RNA	NULL
transcripts	NULL
were	NULL
detected	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
the	NULL
HIV-1	NULL
and	NULL
a-globin	NULL
genes	NULL
.	NULL

The	NULL
a-globin	NULL
gene	NULL
was	NULL
included	NULL
in	NULL
these	NULL
experiments	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
the	NULL
recovery	NULL
of	NULL
RNA	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
control	NULL
to	NULL
show	NULL
that	NULL
transcriptional	NULL
repression	NULL
from	NULL
the	NULL
embryo	NULL
extracts	NULL
required	NULL
chromatin	NULL
templates	NULL
,	NULL
and	NULL
was	NULL
not	NULL
attributable	NULL
to	NULL
nonspecific	NULL
inhibition	NULL
by	NULL
components	NULL
in	NULL
the	NULL
chromatin	NULL
assembly	NULL
extract	NULL
.	NULL

We	NULL
initially	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
TFE-3	NULL
to	NULL
stimulate	NULL
transcription	NULL
from	NULL
reconstituted	NULL
HIV-1	NULL
chromatin	NULL
templates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
promoter-binding	NULL
protein	NULL
Spl	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
3B	NULL
,	NULL
nucleosome	NULL
assembly	NULL
strongly	NULL
represses	NULL
HIV-1	NULL
transcription	NULL
in	NULL
vitro	NULL
{	NULL
lane	NULL
1	NULL
,	NULL
compared	NULL
to	NULL
the	NULL
naked	NULL
DNA	NULL
lane	NULL
}	NULL
.	NULL

Addition	NULL
of	NULL
an	NULL
Spl-enriched	NULL
fraction	NULL
from	NULL
Jurkat	NULL
cells	NULL
derived	NULL
from	NULL
a	NULL
wheat	NULL
germ	NULL
affinity	NULL
(	NULL
WGA	NULL
)	NULL
column	NULL
(	NULL
SplF	NULL
)	NULL
;	NULL
see	NULL
Materials	NULL
and	NULL
methods	NULL
)	NULL
caused	NULL
a	NULL
modest	NULL
derepression	NULL
of	NULL
transcription	NULL
[	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Further	NULL
addition	NULL
of	NULL
purified	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
strongly	NULL
activated	NULL
transcription	NULL
from	NULL
chromatin	NULL
,	NULL
and	NULL
transcription	NULL
was	NULL
further	NULL
augmented	NULL
by	NULL
inclusion	NULL
of	NULL
the	NULL
E-box-binding	NULL
protein	NULL
TFE-3	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
3,4	NULL
)	NULL
.	NULL

PhosphorImager	NULL
scanning	NULL
of	NULL
several	NULL
different	NULL
experiments	NULL
indicates	NULL
that	NULL
the	NULL
combined	NULL
effects	NULL
of	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
TFE-3	NULL
,	NULL
and	NULL
the	NULL
Spl	NULL
fraction	NULL
result	NULL
in	NULL
a	NULL
200-	NULL
to	NULL
450-fold	NULL
derepression	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
.	NULL

Spl	NULL
WGA	NULL
fractions	NULL
from	NULL
Jurkat	NULL
(	NULL
T	NULL
)	NULL
cells	NULL
were	NULL
somewhat	NULL
more	NULL
effective	NULL
than	NULL
comparable	NULL
fractions	NULL
de-	NULL
2094	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
rived	NULL
from	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
cf	NULL
.	NULL

lanes	NULL
5	NULL
and	NULL
7	NULL
)	NULL
,	NULL
although	NULL
both	NULL
fractions	NULL
supported	NULL
activation	NULL
by	NULL
the	NULL
distal	NULL
enhancer-binding	NULL
proteins	NULL
.	NULL

Further	NULL
analysis	NULL
of	NULL
the	NULL
contribution	NULL
of	NULL
individual	NULL
factors	NULL
to	NULL
nucleosomal	NULL
derepression	NULL
indicated	NULL
that	NULL
the	NULL
enhancer-binding	NULL
proteins	NULL
function	NULL
in	NULL
a	NULL
combinatorial	NULL
manner	NULL
with	NULL
Spl	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4A	NULL
,	NULL
preincubation	NULL
of	NULL
HIV-1	NULL
DNA	NULL
with	NULL
high	NULL
levels	NULL
of	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
or	NULL
TFE-3	NULL
prior	NULL
to	NULL
nucleosome	NULL
assembly	NULL
was	NULL
not	NULL
sufficient	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
chromatin	NULL
templates	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Spl	NULL
[	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
9-11	NULL
)	NULL
,	NULL
and	NULL
even	NULL
a	NULL
combination	NULL
of	NULL
all	NULL
three	NULL
distal	NULL
enhancer-binding	NULL
proteins	NULL
resulted	NULL
in	NULL
only	NULL
marginal	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

As	NULL
before	NULL
,	NULL
high	NULL
levels	NULL
of	NULL
transcription	NULL
were	NULL
observed	NULL
when	NULL
the	NULL
Spl	NULL
fraction	NULL
was	NULL
added	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
three	NULL
distal	NULL
enhancer-binding	NULL
proteins	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
Spl	NULL
fraction	NULL
alone	NULL
was	NULL
relatively	NULL
ineffective	NULL
at	NULL
activating	NULL
transcription	NULL
[	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
2	NULL
,	NULL
cf	NULL
.	NULL

the	NULL
fully	NULL
repressed	NULL
DNA	NULL
template	NULL
in	NULL
lane	NULL
1	NULL
}	NULL
.	NULL

Addition	NULL
of	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
to	NULL
the	NULL
Spl	NULL
fraction	NULL
[	NULL
Sp1F	NULL
)	NULL
)	NULL
resulted	NULL
in	NULL
substantial	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
templates	NULL
,	NULL
whereas	NULL
a	NULL
combination	NULL
of	NULL
the	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
proteins	NULL
without	NULL
Spl	NULL
was	NULL
not	NULL
capable	NULL
of	NULL
stimulating	NULL
transcription	NULL
[	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

LEF-1	NULL
,	NULL
but	NULL
not	NULL
Ets-1	NULL
,	NULL
was	NULL
able	NULL
to	NULL
stimulate	NULL
transcription	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
Spl	NULL
fraction	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
cf	NULL
.	NULL

lanes	NULL
5	NULL
and	NULL
6	NULL
with	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Although	NULL
Ets-1	NULL
did	NULL
not	NULL
activate	NULL
alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Spl	NULL
,	NULL
it	NULL
did	NULL
enhance	NULL
transcription	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LEF-1	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
cf	NULL
.	NULL

lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Similar	NULL
combinatorial	NULL
effects	NULL
of	NULL
these	NULL
factors	NULL
were	NULL
observed	NULL
at	NULL
higher	NULL
levels	NULL
of	NULL
the	NULL
Spl	NULL
fraction	NULL
,	NULL
although	NULL
under	NULL
these	NULL
conditions	NULL
it	NULL
was	NULL
possible	NULL
to	NULL
detect	NULL
a	NULL
modest	NULL
activation	NULL
by	NULL
Ets-1	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
LEF-1	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
also	NULL
shows	NULL
that	NULL
TFE-3	NULL
can	NULL
activate	NULL
transcription	NULL
independently	NULL
of	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
when	NULL
added	NULL
to	NULL
the	NULL
SplF	NULL
)	NULL
fraction	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
distal	NULL
enhancer-binding	NULL
proteins	NULL
can	NULL
strongly	NULL
activate	NULL
transcription	NULL
from	NULL
nucleosomal	NULL
DNA	NULL
templates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Spl	NULL
and	NULL
that	NULL
they	NULL
can	NULL
function	NULL
in	NULL
a	NULL
combinatorial	NULL
manner	NULL
.	NULL

In	NULL
the	NULL
experiments	NULL
carried	NULL
out	NULL
here	NULL
,	NULL
relatively	NULL
high	NULL
levels	NULL
of	NULL
all	NULL
of	NULL
the	NULL
enhancer-binding	NULL
proteins	NULL
were	NULL
used	NULL
.	NULL

At	NULL
suboptimal	NULL
levels	NULL
of	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
TFE-3	NULL
,	NULL
the	NULL
synergy	NULL
observed	NULL
with	NULL
different	NULL
combinations	NULL
of	NULL
proteins	NULL
is	NULL
even	NULL
more	NULL
dramatic	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Although	NULL
recombinant	NULL
LEF-1	NULL
strongly	NULL
activates	NULL
transcription	NULL
from	NULL
nucleosomal	NULL
DNA	NULL
templates	NULL
,	NULL
two	NULL
lines	NULL
of	NULL
evidence	NULL
indicate	NULL
that	NULL
it	NULL
can	NULL
not	NULL
stimulate	NULL
transcription	NULL
of	NULL
nonchromatin	NULL
(	NULL
naked	NULL
)	NULL
DNA	NULL
.	NULL

First	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
LEF-1-binding	NULL
site	NULL
in	NULL
the	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
enhancer	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
HIV-1	NULL
transcription	NULL
from	NULL
naked	NULL
DNA	NULL
templates	NULL
that	NULL
have	NULL
been	NULL
transcribed	NULL
with	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
,	NULL
which	NULL
possess	NULL
high	NULL
levels	NULL
of	NULL
endogeneous	NULL
LEF-1	NULL
protein	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
addition	NULL
of	NULL
purified	NULL
LEF-1	NULL
,	NULL
or	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
,	NULL
to	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
failed	NULL
to	NULL
activate	NULL
HIV-1	NULL
transcription	NULL
from	NULL
naked	NULL
DNAs	NULL
in	NULL
vitro	NULL
,	NULL
whether	NULL
tested	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
SpIF	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
8-14	NULL
)	NULL
.	NULL

HIV-1	NULL
transcription	NULL
was	NULL
modestly	NULL
repressed	NULL
when	NULL
higher	NULL
levels	NULL
of	NULL
recombinant	NULL
LEF-1	NULL
were	NULL
added	NULL
to	NULL
HeLa	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
possibly	NULL
because	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
LEF-1	NULL
to	NULL
low-affinity	NULL
sites	NULL
located	NULL
near	NULL
the	NULL
HIV-1	NULL
RNA	NULL
start	NULL
site	NULL
(	NULL
Waterman	NULL
and	NULL
Jones	NULL
1990	NULL
)	NULL
.	NULL

Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Micrococcal	NULL
Nuclease	NULL
Digestion	NULL
2	NULL
'	NULL
-	NULL
»	NULL
25°	NULL
2°	NULL
-	NULL
»	NULL
25°	NULL
2	NULL
'	NULL
-*	NULL
»	NULL
25	NULL
t	NULL
C	NULL
0	NULL
$	NULL
1103	NULL
UC	NULL
Ctg	NULL
t	NULL
Chromatin-dependent	NULL
trans-activation	NULL
by	NULL
LEF-1	NULL
Figure	NULL
3	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Analysis	NULL
of	NULL
chromatin	NULL
reconstituted	NULL
with	NULL
Drosophila	NULL
embryo	NULL
extracts	NULL
by	NULL
MNase	NULL
digestion	NULL
,	NULL
as	NULL
visualized	NULL
by	NULL
staining	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

Supercoiled	NULL
HIV-1	NULL
plasmid	NULL
DNA	NULL
(	NULL
5.1	NULL
kb	NULL
}	NULL
was	NULL
incubated	NULL
with	NULL
Drosophila	NULL
$	NULL
-190	NULL
extract	NULL
,	NULL
an	NULL
ATP-regenerating	NULL
system	NULL
,	NULL
purified	NULL
core	NULL
histones	NULL
,	NULL
and	NULL
varying	NULL
amounts	NULL
of	NULL
purified	NULL
histone	NULL
H1	NULL
,	NULL
for	NULL
5	NULL
br	NULL
at	NULL
30°C	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
methods	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
histone	NULL
H1	NULL
used	NULL
in	NULL
the	NULL
three	NULL
micrococcal	NULL
digests	NULL
shown	NULL
above	NULL
{	NULL
left	NULL
to	NULL
right	NULL
]	NULL
was	NULL
0.21	NULL
,	NULL
0.24	NULL
,	NULL
and	NULL
0.3	NULL
ug/ug	NULL
of	NULL
DNA	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
chromatin	NULL
was	NULL
partially	NULL
digested	NULL
with	NULL
MNase	NULL
for	NULL
varying	NULL
amounts	NULL
of	NULL
time	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
9	NULL
,	NULL
16	NULL
,	NULL
and	NULL
25	NULL
min	NULL
]	NULL
as	NULL
indicated	NULL
above	NULL
the	NULL
lanes	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
fragments	NULL
derived	NULL
from	NULL
mono-	NULL
and	NULL
oligonucleosomes	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
in	NULL
a	NULL
1.25	NULL
%	NULL
{	NULL
wt/	NULL
vol	NULL
)	NULL
agarose	NULL
gel	NULL
.	NULL

For	NULL
reference	NULL
,	NULL
the	NULL
marker	NULL
lane	NULL
displays	NULL
a	NULL
1-kb	NULL
DNA	NULL
ladder	NULL
(	NULL
GIBCO-BRL	NULL
)	NULL
.	NULL

The	NULL
optimal	NULL
level	NULL
of	NULL
histone	NULL
HI	NULL
(	NULL
0.24	NULL
pg/pg	NULL
DNA	NULL
)	NULL
was	NULL
used	NULL
for	NULL
subsequent	NULL
transcription	NULL
reactions	NULL
.	NULL

Parallel	NULL
reactions	NULL
containing	NULL
or	NULL
lacking	NULL
different	NULL
purified	NULL
enhancer-	NULL
and	NULL
promoter-binding	NULL
proteins	NULL
were	NULL
subsequently	NULL
used	NULL
as	NULL
nucleosomal	NULL
DNA	NULL
¥	NULL
templates	NULL
for	NULL
in	NULL
vitro	NULL
transcription	NULL
,	NULL
as	NULL
indicated	NULL
|	NULL
(	NULL
1	NULL
DNA-binding	NULL
factors	NULL
Chromatin	NULL
Extract	NULL
||	NULL
HIV-1	NULL
DNA	NULL
Transcription	NULL
Core	NULL
Histones	NULL
ATP	NULL
Regenerating	NULL
Extract	NULL
Primer	NULL
Histone	NULL
H1	NULL
System	NULL
a-globin	NULL
DNA	NULL
rNTPs	NULL
extension	NULL
a	NULL
t	NULL
i	NULL
'	NULL
30	NULL
min	NULL
,	NULL
25°C	NULL
5	NULL
hr	NULL
,	NULL
30°C	NULL
20	NULL
min	NULL
,	NULL
25°C	NULL
I	NULL
30	NULL
min	NULL
,	NULL
30°C	NULL
Nucleosome	NULL
Assembly	NULL
tres	NULL
LEF	NULL
LEF	NULL
flats	NULL
Ets	NULL
ETs	NULL
x	NULL
LEF	NULL
TFE-3	NULL
TFE-3	NULL
(	NULL
<	NULL
9	NULL
ETS	NULL
--	NULL
-	NULL
#	NULL
m-	NULL
y	NULL
HM	NULL
_-	NULL
Sp1FJ	NULL
-	NULL
-_-	NULL
»	NULL
Sp1FH	NULL
--	NULL
»	NULL
&	NULL
Comparison	NULL
of	NULL
Spl-entiched	NULL
WGA	NULL
fractions	NULL
(	NULL
§p1F	NULL
]	NULL
)	NULL
with	NULL
purified	NULL
Sp1	NULL
The	NULL
§p1lF	NULL
)	NULL
fraction	NULL
used	NULL
in	NULL
the	NULL
previous	NULL
experiments	NULL
was	NULL
isolated	NULL
by	NULL
WGA	NULL
chromatography	NULL
,	NULL
which	NULL
enriches	NULL
Spl	NULL
~200-fold	NULL
from	NULL
crude	NULL
nuclear	NULL
extracts	NULL
(	NULL
Jackson	NULL
and	NULL
Tjian	NULL
1989	NULL
)	NULL
.	NULL

Although	NULL
DNase	NULL
I	NULL
footprint	NULL
experiments	NULL
suggest	NULL
that	NULL
Spl	NULL
is	NULL
the	NULL
only	NULL
HIV-1	NULL
DNA-binding	NULL
protein	NULL
present	NULL
In	NULL
vitro	NULL
Transcription	NULL
u	NULL
'	NULL
-	NULL
<	NULL
HIV	NULL
.	NULL
'	NULL

.	NULL
'	NULL

'	NULL
<	NULL
-globin	NULL
in	NULL
the	NULL
schematic	NULL
diagram	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Analysis	NULL
of	NULL
transcription	NULL
from	NULL
nucleosomal	NULL
DNA	NULL
templates	NULL
reconstituted	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lane	NULL
1	NULL
}	NULL
or	NULL
presence	NULL
(	NULL
lanes	NULL
2-8	NULL
)	NULL
of	NULL
different	NULL
enhancer-	NULL
or	NULL
promoter-binding	NULL
proteins	NULL
.	NULL

Prior	NULL
to	NULL
nucleosome	NULL
assembly	NULL
,	NULL
the	NULL
HIV-1	NULL
DNA	NULL
templates	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
Spl	NULL
fraction	NULL
derived	NULL
from	NULL
either	NULL
Jurkat	NULL
(	NULL
SplF	NULL
)	NULL
;	NULL
lanes	NULL
2-6	NULL
)	NULL
or	NULL
Hela	NULL
cells	NULL
(	NULL
SpIFH	NULL
;	NULL
lanes	NULL
7,8	NULL
)	NULL
and	NULL
tested	NULL
alone	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
,	NULL
respec-tively	NULL
)	NULL
in	NULL
combination	NULL
with	NULL
purified	NULL
recombinant	NULL
LEPF-1	NULL
and	NULL
Ets-1	NULL
proteins	NULL
(	NULL
lane	NULL
3	NULL
}	NULL
,	NULL
or	NULL
with	NULL
all	NULL
three	NULL
recombinant	NULL
enhancer-binding	NULL
proteins	NULL
(	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
TFE-3	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

«	NULL
-Globin	NULL
DNA	NULL
was	NULL
added	NULL
following	NULL
nucleosome	NULL
assembly	NULL
to	NULL
serve	NULL
as	NULL
a	NULL
control	NULL
for	NULL
RNA	NULL
recovery	NULL
.	NULL

Naked	NULL
DNA	NULL
lanes	NULL
show	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
HIV-1	NULL
and	NULL
«	NULL
-globin	NULL
promoters	NULL
that	NULL
were	NULL
not	NULL
subjected	NULL
to	NULL
nucleosome	NULL
assembly	NULL
{	NULL
nonchromatin	NULL
templates	NULL
)	NULL
.	NULL

HIV-1	NULL
and	NULL
a-globin	NULL
RNA	NULL
transcripts	NULL
were	NULL
detected	NULL
by	NULL
primer	NULL
extension	NULL
.	NULL

in	NULL
these	NULL
fractions	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
this	NULL
fraction	NULL
provides	NULL
additional	NULL
cofactors	NULL
that	NULL
are	NULL
necessary	NULL
for	NULL
HIV-1	NULL
promoter	NULL
activity	NULL
,	NULL
and	NULL
we	NULL
have	NULL
detected	NULL
TATA-binding	NULL
protein	NULL
{	NULL
TBP	NULL
)	NULL
and	NULL
TBP-associated	NULL
factors	NULL
(	NULL
TAF	NULL
)	NULL
=-250	NULL
and	NULL
-150	NULL
proteins	NULL
in	NULL
active	NULL
WGA	NULL
(	NULL
SpIF	NULL
]	NULL
)	NULL
fractions	NULL
by	NULL
Western	NULL
blots	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
potential	NULL
contribution	NULL
of	NULL
other	NULL
factors	NULL
in	NULL
the	NULL
derepression	NULL
assay	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
relative	NULL
activity	NULL
of	NULL
the	NULL
Sp1F	NULL
)	NULL
fraction	NULL
with	NULL
recombinant	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
2095	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Sheridan	NULL
et	NULL
al	NULL
.	NULL

A	NULL
LEF	NULL
ETS	NULL
HM	NULL
_	NULL
Sp1FJ	NULL
Sp1FJ	NULL
TFE-3	NULL
TFE-3	NULL
-	NULL
-	NULL
TFE-3	NULL
Ry	NULL
LEF	NULL
_	NULL
-	NULL
LEF	NULL
LEF	NULL
LEF	NULL
-	NULL
-	NULL
9°	NULL
-	NULL
-	NULL
Ets	NULL
ETs	NULL
ETs	NULL
-_	NULL
--	NULL
Ets	NULL
-	NULL
$	NULL
0	NULL
Sp1FJ	NULL
SpIFJ	NULL
SpiFJ	NULL
-	NULL
-	NULL
-	NULL
-	NULL
by	NULL
aw	NULL
-	NULL
>	NULL
#	NULL
#	NULL
~	NULL
>	NULL
#	NULL
#	NULL
x	NULL
a	NULL
s	NULL
@	NULL
8	NULL
s	NULL
s	NULL
s	NULL
888	NULL
8	NULL
9	NULL
<	NULL
a-globin	NULL
-C	NULL
388	NULL
z	NULL
z=	NULL
s	NULL
88s	NULL
#	NULL
qo	NULL
2	NULL
o	NULL
8s	NULL
0	NULL
40	NULL
506	NULL
7	NULL
8	NULL
9	NULL
40	NULL
1	NULL
Figure	NULL
4	NULL
.	NULL

-	NULL
Combinatorial	NULL
effects	NULL
of	NULL
different	NULL
enhancer-binding	NULL
proteins	NULL
on	NULL
HIV-1	NULL
B	NULL
&	NULL
>	NULL
transcription	NULL
from	NULL
nucleosomal	NULL
DNA	NULL
LEF	NULL
r	NULL
¢	NULL
ue	NULL
>	NULL
Qg	NULL
‘	NULL
}	NULL
templates	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
various	NULL
protein	NULL
LEF	NULL
ETS4	NULL
tres	NULL
$	NULL
22	NULL
;	NULL
(	NULL
9°	NULL
©	NULL
,	NULL
.A	NULL
«	NULL
$	NULL
39	NULL
?	NULL

y*	NULL
fraction	NULL
additions	NULL
included	NULL
during	NULL
nucleo-	NULL
HM	NULL
-	NULL
Sp1FJ	NULL
SpiFJ	NULL
G	NULL
pRRZLR	NULL
RR	NULL
some	NULL
assembly	NULL
of	NULL
DNA	NULL
templates	NULL
are	NULL
in-	NULL
mor-	NULL
r	NULL
--	NULL
_	NULL
r-	NULL
r-	NULL
$	NULL
x	NULL
kx	NULL
``	NULL
ox	NULL
x	NULL
dicated	NULL
above	NULL
each	NULL
lane	NULL
;	NULL
HM	NULL
{	NULL
lane	NULL
1	NULL
)	NULL
is	NULL
a	NULL
control	NULL
reaction	NULL
to	NULL
which	NULL
no	NULL
enhancer-binding	NULL
proteins	NULL
were	NULL
added	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
TFE-3	NULL
used	NULL
are	NULL
listed	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

Reactions	NULL
in	NULL
A	NULL
received	NULL
10	NULL
pl	NULL
of	NULL
SplF	NULL
]	NULL
,	NULL
whereas	NULL
reactions	NULL
|	NULL
<	NULL
co-giobin	NULL
in	NULL
B	NULL
contained	NULL
20	NULL
wl	NULL
of	NULL
SplF	NULL
)	NULL
(	NULL
lanes	NULL
1-6	NULL
)	NULL
.	NULL

#	NULL
The	NULL
influence	NULL
of	NULL
recombinant	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
proteins	NULL
on	NULL
naked	NULL
DNA	NULL
was	NULL
tested	NULL
in	NULL
lanes	NULL
8-14	NULL
{	NULL
see	NULL
Materials	NULL
and	NULL
methods	NULL
}	NULL
.	NULL

10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
91011121344	NULL
Spl	NULL
protein	NULL
as	NULL
well	NULL
as	NULL
with	NULL
Spl	NULL
protein	NULL
purified	NULL
by	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
from	NULL
the	NULL
Jurkat	NULL
WGA	NULL
fraction	NULL
.	NULL

Although	NULL
Spl	NULL
was	NULL
not	NULL
able	NULL
to	NULL
strongly	NULL
derepress	NULL
HIV-1	NULL
transcription	NULL
on	NULL
its	NULL
own	NULL
,	NULL
both	NULL
recombinant	NULL
and	NULL
purified	NULL
Spl	NULL
stimulated	NULL
transcription	NULL
when	NULL
added	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
enhancer-binding	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
cf	NULL
.	NULL

lane	NULL
4	NULL
with	NULL
lanes	NULL
5-7	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
purified	NULL
Spl	NULL
to	NULL
enhance	NULL
transcription	NULL
was	NULL
less	NULL
than	NULL
that	NULL
observed	NULL
with	NULL
the	NULL
SpIFJ	NULL
fraction	NULL
(	NULL
cf	NULL
.	NULL

lane	NULL
3	NULL
with	NULL
lanes	NULL
5-7	NULL
)	NULL
regardless	NULL
of	NULL
whether	NULL
the	NULL
distal	NULL
enhancer-binding	NULL
proteins	NULL
were	NULL
included	NULL
in	NULL
the	NULL
reactions	NULL
.	NULL

Nevertheless	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
can	NULL
activate	NULL
transcription	NULL
in	NULL
combination	NULL
with	NULL
purified	NULL
Spl	NULL
on	NULL
nucleosome	NULL
DNA	NULL
templates	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
whether	NULL
other	NULL
factors	NULL
present	NULL
in	NULL
the	NULL
WGA	NULL
fraction	NULL
,	NULL
possibly	NULL
including	NULL
TBP	NULL
and	NULL
the	NULL
TAF	NULL
proteins	NULL
,	NULL
can	NULL
assist	NULL
derepression	NULL
of	NULL
HIV-1	NULL
transcription	NULL
by	NULL
Spl	NULL
in	NULL
these	NULL
assays	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
the	NULL
stimulation	NULL
we	NULL
observed	NULL
in	NULL
these	NULL
assays	NULL
is	NULL
attributable	NULL
to	NULL
derepression	NULL
of	NULL
transcription	NULL
by	NULL
the	NULL
enhancer-binding	NULL
proteins	NULL
and	NULL
the	NULL
Spl	NULL
fraction	NULL
,	NULL
rather	NULL
than	NULL
interference	NULL
of	NULL
these	NULL
proteins	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
chromatin	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
these	NULL
proteins	NULL
on	NULL
nucleosome	NULL
assembly	NULL
was	NULL
assessed	NULL
by	NULL
MNase	NULL
digestion	NULL
of	NULL
the	NULL
same	NULL
chromatin	NULL
templates	NULL
prepared	NULL
for	NULL
transcriptional	NULL
analysis	NULL
following	NULL
preincubation	NULL
with	NULL
the	NULL
Spl	NULL
fraction	NULL
or	NULL
the	NULL
enhancer-binding	NULL
proteins	NULL
.	NULL

The	NULL
results	NULL
revealed	NULL
that	NULL
the	NULL
Sp1F	NULL
]	NULL
)	NULL
fraction	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
nucleosome	NULL
2096	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
assembly	NULL
process	NULL
,	NULL
either	NULL
when	NULL
added	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
LEF-1	NULL
,	NULL
or	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
addition	NULL
of	NULL
TFE-3	NULL
to	NULL
the	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
Spl	NULL
fraction	NULL
did	NULL
not	NULL
disturb	NULL
the	NULL
MNase	NULL
digestion	NULL
pattern	NULL
of	NULL
the	NULL
bulk	NULL
chromatin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
proteins	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
do	NULL
not	NULL
influence	NULL
chromatin	NULL
assembly	NULL
by	NULL
the	NULL
Drosophila	NULL
embryo	NULL
extracts	NULL
.	NULL

More	NULL
detailed	NULL
structural	NULL
studies	NULL
are	NULL
under	NULL
way	NULL
to	NULL
characterize	NULL
the	NULL
changes	NULL
in	NULL
the	NULL
local	NULL
chromatin	NULL
structure	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
and	NULL
enhancer	NULL
that	NULL
are	NULL
induced	NULL
upon	NULL
the	NULL
binding	NULL
of	NULL
these	NULL
different	NULL
enhancer	NULL
proteins	NULL
.	NULL

Specific	NULL
binding	NULL
of	NULL
LEF-1	NULL
to	NULL
the	NULL
distal	NULL
HIV-1	NULL
enhancer	NULL
is	NULL
necessary	NULL
for	NULL
transcriptional	NULL
activation	NULL
in	NULL
vitro	NULL
LEF-1	NULL
differs	NULL
from	NULL
proteins	NULL
such	NULL
as	NULL
HMG-1/2	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
and	NULL
activate	NULL
transcription	NULL
through	NULL
specific	NULL
sites	NULL
in	NULL
the	NULL
DNA	NULL
,	NULL
and	NULL
transient	NULL
transfection	NULL
experiments	NULL
with	NULL
multimerized	NULL
enhancer	NULL
constructs	NULL
indicate	NULL
that	NULL
specific	NULL
binding	NULL
of	NULL
LEF-1	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
in	NULL
vivo	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
effects	NULL
of	NULL
LEF-1	NULL
in	NULL
the	NULL
chromatin	NULL
derepression	NULL
assay	NULL
are	NULL
attributable	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
LEF-1	NULL
to	NULL
the	NULL
distal	NULL
part	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
,	NULL
we	NULL
tested	NULL
a	NULL
promoter	NULL
containing	NULL
a	NULL
5-bp	NULL
mutation	NULL
in	NULL
the	NULL
LEF-1	NULL
-binding	NULL
site	NULL
at	NULL
-	NULL
122	NULL
to	NULL
-142	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
6	NULL
,	NULL
the	NULL
LEF-1	NULL
mutant	NULL
promoter	NULL
(	NULL
LM	NULL
;	NULL
lanes	NULL
5	NULL
,	NULL
7	NULL
)	NULL
was	NULL
reduced	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
respond	NULL
to	NULL
acti-	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
LEF	NULL
LEF	NULL
LEF	NULL
LEF	NULL
LEF	NULL
ETS-1	NULL
ETS	NULL
ETS-1	NULL
ETS-1	NULL
ETS-1	NULL
TFE-3	NULL
TFE-3	NULL
TFE-3	NULL
TFE-3	NULL
TFE-3	NULL
HM	NULL
-	NULL
Sp1FJ	NULL
SpIFJ	NULL
--	NULL
r	NULL
Sp1	NULL
p	NULL
Sp1	NULL
BSA	NULL
MCA	NULL
-	NULL
-a	NULL
-a	NULL
~	NULL
@	NULL
C	NULL
@	NULL
~	NULL
sees	NULL
s	NULL
@	NULL
a	NULL
-	NULL
'	NULL
<	NULL
-	NULL
HIV-1	NULL
'	NULL
--	NULL
o-globin	NULL
Chromatin-dependent	NULL
trans-activation	NULL
by	NULL
LEF-1	NULL
ETS	NULL
LEF	NULL
LEF	NULL
m-	NULL
r	NULL
--	NULL
NONE	NULL
SP1FJ	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
#	NULL
»	NULL
2'-	NULL
»	NULL
25	NULL
2-	NULL
»	NULL
25°	NULL
25	NULL
2	NULL
-	NULL
»	NULL
25	NULL
Figure	NULL
5	NULL
.	NULL

-	NULL
Comparison	NULL
of	NULL
the	NULL
relative	NULL
activities	NULL
of	NULL
the	NULL
SpIF	NULL
)	NULL
fraction	NULL
and	NULL
purified	NULL
Spl	NULL
protein	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Recombinant	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
TFE-3	NULL
were	NULL
included	NULL
during	NULL
assembly	NULL
of	NULL
the	NULL
nucleosomal	NULL
templates	NULL
either	NULL
alone	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
together	NULL
with	NULL
15	NULL
ul	NULL
of	NULL
SpIF	NULL
]	NULL
)	NULL
(	NULL
the	NULL
WGA-purified	NULL
Spl	NULL
fraction	NULL
from	NULL
Jurkat	NULL
cells	NULL
;	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
0.5	NULL
ug	NULL
and	NULL
1	NULL
mug	NULL
recombinant	NULL
Spl	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
or	NULL
0.75	NULL
ug	NULL
of	NULL
Spl	NULL
purified	NULL
from	NULL
Jurkat	NULL
nuclei	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
(	NULL
HM	NULL
)	NULL
shows	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
from	NULL
a	NULL
repressed	NULL
template	NULL
,	NULL
and	NULL
reactions	NULL
containing	NULL
15	NULL
ul	NULL
of	NULL
the	NULL
Sp1lF	NULL
]	NULL
or	NULL
3	NULL
ug	NULL
of	NULL
acetylated	NULL
BSA	NULL
are	NULL
shown	NULL
in	NULL
lanes	NULL
2	NULL
and	NULL
8	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
B	NULL
)	NULL
MNase	NULL
analysis	NULL
of	NULL
nucleosomes	NULL
assembled	NULL
onto	NULL
DNA	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
SpIFJ	NULL
,	NULL
LEF-1	NULL
,	NULL
and	NULL
Ets-1	NULL
fractions	NULL
,	NULL
as	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
.	NULL

These	NULL
reactions	NULL
demonstrate	NULL
that	NULL
the	NULL
purified	NULL
enhancer-binding	NULL
proteins	NULL
do	NULL
not	NULL
interfere	NULL
with	NULL
nucleosome	NULL
assembly	NULL
.	NULL

vation	NULL
by	NULL
either	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
or	NULL
by	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
TFE-3	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
HIV-1	NULL
promoter	NULL
(	NULL
WT	NULL
;	NULL
lanes	NULL
4,6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
LEF-1	NULL
mutant	NULL
DNA	NULL
was	NULL
as	NULL
active	NULL
as	NULL
the	NULL
wild-type	NULL
promoter	NULL
on	NULL
naked	NULL
DNA	NULL
templates	NULL
transcribed	NULL
in	NULL
the	NULL
Hela	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
and	NULL
the	NULL
same	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
the	NULL
two	NULL
DNAs	NULL
were	NULL
transcribed	NULL
in	NULL
HeLa	NULL
extracts	NULL
supplemented	NULL
with	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
or	NULL
in	NULL
Jurkat	NULL
extracts	NULL
,	NULL
which	NULL
contain	NULL
high	NULL
levels	NULL
of	NULL
endogeneous	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
LEF-1	NULL
activation	NULL
on	NULL
chromatin	NULL
requires	NULL
the	NULL
distal	NULL
enhancer-binding	NULL
site	NULL
and	NULL
occurs	NULL
through	NULL
a	NULL
process	NULL
that	NULL
is	NULL
not	NULL
evident	NULL
on	NULL
naked	NULL
DNA	NULL
templates	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
LEF-1	NULL
trans-activation	NULL
domain	NULL
is	NULL
required	NULL
to	NULL
activate	NULL
HIV-1	NULL
transcription	NULL
from	NULL
nucleosomal	NULL
DNA	NULL
templates	NULL
in	NULL
vitro	NULL
:	NULL
binding	NULL
and	NULL
bending	NULL
of	NULL
DNA	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
stimulate	NULL
transcription	NULL
The	NULL
ability	NULL
of	NULL
LEF-1	NULL
to	NULL
bend	NULL
DNA	NULL
strongly	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
multiprotein	NULL
complex	NULL
at	NULL
the	NULL
TCRa	NULL
«	NULL
enhancer	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
mechanisms	NULL
proposed	NULL
for	NULL
activation	NULL
by	NULL
other	NULL
architectural	NULL
transcription	NULL
factors	NULL
[	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Grossched	NULL
]	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
;	NULL
Tjian	NULL
and	NULL
Maniatis	NULL
1994	NULL
)	NULL
.	NULL

As	NULL
we	NULL
reported	NULL
pre-viously	NULL
,	NULL
however	NULL
,	NULL
the	NULL
full-length	NULL
LEF-1	NULL
protein	NULL
,	NULL
but	NULL
not	NULL
the	NULL
LEF-1	NULL
HMG	NULL
domain	NULL
,	NULL
is	NULL
capable	NULL
of	NULL
activating	NULL
the	NULL
TCRa	NULL
«	NULL
enhancer	NULL
upon	NULL
transfection	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
Carlsson	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
chimeric	NULL
LEF-1/GAL4	NULL
{	NULL
or	NULL
LEF-1/LexA	NULL
)	NULL
strongly	NULL
stimulates	NULL
the	NULL
TCRa	NULL
enhancer	NULL
in	NULL
vivo	NULL
in	NULL
spite	NULL
of	NULL
its	NULL
inability	NULL
to	NULL
bend	NULL
DNA	NULL
(	NULL
Carlsson	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
;	NULL
Giese	NULL
and	NULL
Grosschedl	NULL
1993	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
studies	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
amino-terminal	NULL
activation	NULL
domain	NULL
is	NULL
important	NULL
for	NULL
LEF-1	NULL
activity	NULL
.	NULL

These	NULL
find	NULL
LEF	NULL
LEF	NULL
ETS-1	NULL
ETSA	NULL
C	NULL
TFE-3	NULL
9°	NULL
&	NULL
«	NULL
<	NULL
I-	NULL
HM	NULL
-	NULL
_	NULL
SpIFJ	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
»	NULL
e	NULL
DNA	NULL
:	NULL
WT	NULL
-	NULL
LM	NULL
WT	NULL
WT	NULL
LM	NULL
WT	NULL
LM	NULL
-	NULL
WT	NULL
LM	NULL
mar-	NULL
r-	NULL
t-	NULL
r	NULL
--	NULL
m-	NULL
t-	NULL
mom	NULL
<	NULL
-	NULL
a-globin	NULL
&	NULL
«	NULL
o	NULL
«	NULL
o	NULL
«	NULL
-	NULL
C	NULL
«	NULL
»	NULL
ap	NULL
as	NULL
«	NULL
-	NULL
«	NULL
s	NULL
Ch	NULL
p	NULL
Do	NULL
4	NULL
Figure	NULL
6	NULL
.	NULL

-	NULL
Activation	NULL
of	NULL
HIV-1	NULL
nucleosomal	NULL
templates	NULL
by	NULL
LEF-1	NULL
in	NULL
vitro	NULL
requires	NULL
the	NULL
distal	NULL
LEF-l-binding	NULL
site	NULL
in	NULL
the	NULL
enhancer	NULL
.	NULL

Nucleosomal	NULL
DNA	NULL
transcriptions	NULL
were	NULL
carried	NULL
out	NULL
using	NULL
the	NULL
wild-type	NULL
HIV-1	NULL
enhancer	NULL
[	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
a	NULL
mutant	NULL
enhancer	NULL
containing	NULL
a	NULL
5-base	NULL
substitution	NULL
in	NULL
the	NULL
LEF-1	NULL
binding	NULL
site	NULL
{	NULL
LM	NULL
}	NULL
,	NULL
as	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
.	NULL

Nucleosome	NULL
assembly	NULL
reactions	NULL
either	NULL
lacked	NULL
enhancer-binding	NULL
proteins	NULL
{	NULL
lanes	NULL
1,2	NULL
)	NULL
,	NULL
or	NULL
contained	NULL
SpIFJ	NULL
alone	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
(	NULL
lanes	NULL
4,5	NULL
)	NULL
or	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
TFE-3	NULL
(	NULL
lanes	NULL
6,7	NULL
)	NULL
.	NULL

Equivalent	NULL
transcription	NULL
was	NULL
observed	NULL
from	NULL
the	NULL
wild-type	NULL
and	NULL
LEF-1	NULL
mutant	NULL
DNAs	NULL
on	NULL
nonchromatin	NULL
(	NULL
naked	NULL
DNA	NULL
)	NULL
templates	NULL
.	NULL

GENES	NULL
&	NULL
DEVELOPMENT	NULL
2097	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Sheridan	NULL
et	NULL
al	NULL
.	NULL

ings	NULL
contrast	NULL
with	NULL
those	NULL
of	NULL
Giese	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
,	NULL
in	NULL
which	NULL
the	NULL
HMG	NULL
domains	NULL
of	NULL
either	NULL
LEF-1	NULL
or	NULL
SRY	NULL
were	NULL
reported	NULL
to	NULL
activate	NULL
a	NULL
TCRa	NULL
chloramphenicol	NULL
acetyltransferase	NULL
{	NULL
(	NULL
CAT	NULL
)	NULL
construct	NULL
half	NULL
as	NULL
well	NULL
as	NULL
the	NULL
full-length	NULL
LEF-1	NULL
protein	NULL
{	NULL
two-	NULL
vs.	NULL
fourfold	NULL
activation	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
difficult	NULL
to	NULL
assess	NULL
the	NULL
relative	NULL
importance	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
using	NULL
transient	NULL
expression	NULL
assays	NULL
,	NULL
which	NULL
support	NULL
only	NULL
a	NULL
modest	NULL
activation	NULL
by	NULL
LEF-1	NULL
,	NULL
or	NULL
through	NULL
studies	NULL
with	NULL
chimeric	NULL
proteins	NULL
,	NULL
in	NULL
which	NULL
the	NULL
activation	NULL
domain	NULL
must	NULL
function	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
bending	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
chromatin	NULL
derepression	NULL
assay	NULL
circumvents	NULL
some	NULL
of	NULL
these	NULL
problems	NULL
because	NULL
it	NULL
is	NULL
quite	NULL
sensitive	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
native	NULL
LEF-1	NULL
protein	NULL
{	NULL
con-taining	NULL
both	NULL
the	NULL
trans-activation	NULL
and	NULL
HMG	NULL
domains	NULL
)	NULL
and	NULL
measures	NULL
activation	NULL
by	NULL
LEF-1	NULL
through	NULL
the	NULL
intact	NULL
HIV-1	NULL
promoter/enhancer	NULL
,	NULL
rather	NULL
than	NULL
relying	NULL
on	NULL
artificial	NULL
constructs	NULL
in	NULL
which	NULL
minimal	NULL
enhancer	NULL
elements	NULL
are	NULL
fused	NULL
to	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

To	NULL
begin	NULL
to	NULL
define	NULL
the	NULL
domains	NULL
of	NULL
LEF-1	NULL
that	NULL
are	NULL
required	NULL
to	NULL
activate	NULL
chromatin	NULL
templates	NULL
in	NULL
vitro	NULL
,	NULL
we	NULL
expressed	NULL
and	NULL
purified	NULL
a	NULL
LEF-1	NULL
amino-terminal	NULL
truncation	NULL
A	NULL
x	NULL
LEF	NULL
_	NULL
HMG	NULL
$	NULL
LEF	NULL
HMG	NULL
Ets	NULL
ETs	NULL
439	NULL
ets	NULL
Ets	NULL
tres	NULL
Tres	NULL
-	NULL
\y	NULL
``	NULL
HM	NULL
Sp1FJ	NULL
of	NULL
-a	NULL
-q	NULL
m-	NULL
f-	NULL
f	NULL
-	NULL
<	NULL
HIV~1	NULL
or	NULL
es	NULL
~..ﬂ	NULL
``	NULL
”	NULL
mutant	NULL
that	NULL
contains	NULL
the	NULL
HMG	NULL
box	NULL
and	NULL
an	NULL
adjacent	NULL
carboxy-terminal	NULL
20-amino-acid	NULL
basic	NULL
motif	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
required	NULL
for	NULL
high-affinity	NULL
binding	NULL
.to	NULL
DNA	NULL
(	NULL
Carlsson	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

This	NULL
88-amino-acid	NULL
protein	NULL
(	NULL
called	NULL
HMG-88	NULL
;	NULL
amino	NULL
acids	NULL
297-384	NULL
)	NULL
,	NULL
completely	NULL
lacks	NULL
the	NULL
trans-activation	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
80-256	NULL
)	NULL
that	NULL
was	NULL
defined	NULL
previously	NULL
in	NULL
vivo	NULL
(	NULL
Carlsson	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
HMG-88	NULL
was	NULL
much	NULL
less	NULL
active	NULL
than	NULL
the	NULL
full-length	NULL
LEF-1	NULL
protein	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
Ets-1	NULL
or	NULL
Ets-1	NULL
and	NULL
TFE-3	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

The	NULL
HMG-88	NULL
protein	NULL
was	NULL
also	NULL
inactive	NULL
when	NULL
tested	NULL
alone	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
complement	NULL
the	NULL
SpIF	NULL
)	NULL
frac-tion	NULL
;	NULL
however	NULL
,	NULL
activation	NULL
by	NULL
the	NULL
full-length	NULL
LEF-1	NULL
protein	NULL
was	NULL
modest	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
,	NULL
;	NULL
cf	NULL
.	NULL

Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
sequences	NULL
outside	NULL
of	NULL
the	NULL
HMG	NULL
domain	NULL
are	NULL
critical	NULL
for	NULL
LEF-1	NULL
activation	NULL
in	NULL
vitro	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
HMG-88	NULL
protein	NULL
was	NULL
equivalent	NULL
to	NULL
the	NULL
full-length	NULL
LEF-1	NULL
protein	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
DNA	NULL
in	NULL
a	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
cf	NULL
.	NULL

lanes	NULL
2	NULL
and	NULL
10	NULL
)	NULL
.	NULL

The	NULL
circular	NULL
permutation	NULL
gel-shift	NULL
assay	NULL
used	NULL
to	NULL
evaluate	NULL
bending	NULL
revealed	NULL
that	NULL
the	NULL
HMG-88	NULL
protein	NULL
also	NULL
bends	NULL
DNA	NULL
approximately	NULL
128°	NULL
,	NULL
to	NULL
an	NULL
extent	NULL
~	NULL
|	NULL
I	NULL
ll	NULL
..	NULL
”	NULL
,	NULL
<	NULL
c-globin	NULL
B	NULL
-	NULL
por	NULL
wm	NULL
&	NULL
d	NULL
a	NULL
im	NULL
.	NULL

--	NULL
wn	NULL
-o	NULL
dg	NULL
oo	NULL
*	NULL
256	NULL
297	NULL
Basic	NULL
399	NULL
Trans-Activation	NULL
DNA-binding	NULL
Domain	NULL
Domain	NULL
Basic	NULL
297	NULL
384	NULL
DNA-binding	NULL
Domain	NULL
|	NULL
ane	NULL
|Z	NULL
__|	NULL
hLEF	NULL
FL	NULL
-	NULL
hLEF	NULL
HMG	NULL
-	NULL
88	NULL
RI	NULL
H3	NULL
Bs	NULL
RV	NULL
N	NULL
Bam	NULL
RI	NULL
H3	NULL
Bs	NULL
RV	NULL
N	NULL
Bam	NULL
wilhus	NULL
f	NULL
is	NULL
ﬁkii	NULL
wine	NULL
wins	NULL
=	NULL
>	NULL
Cane	NULL
Wit	NULL
:	NULL
hi	NULL
:	NULL
--	NULL
``	NULL
“	NULL
J=	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
111213141516	NULL
17	NULL
HMG	NULL
-	NULL
88	NULL
aa	NULL
RI	NULL
H3	NULL
BstNl	NULL
RI	NULL
H3	NULL
BstNl	NULL
RV	NULL
Nhe	NULL
Bam	NULL
AV	NULL
-	NULL
Nhe	NULL
Bam	NULL
Figure	NULL
7	NULL
.	NULL

-	NULL
Transcriptional	NULL
activation	NULL
by	NULL
LEF-1	NULL
on	NULL
HIV-1	NULL
chromatin	NULL
in	NULL
vitro	NULL
requires	NULL
the	NULL
amino-terminal	NULL
trans-activation	NULL
domain	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Comparison	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
full-length	NULL
LEF-1	NULL
protein	NULL
with	NULL
the	NULL
HMG-88	NULL
mutant	NULL
{	NULL
amino	NULL
acids	NULL
297-384	NULL
)	NULL
that	NULL
contains	NULL
only	NULL
the	NULL
HMG	NULL
and	NULL
downstream	NULL
basic	NULL
domain	NULL
.	NULL

Reactions	NULL
either	NULL
lacked	NULL
enhancer-binding	NULL
proteins	NULL
in	NULL
the	NULL
preincubation	NULL
step	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
or	NULL
contained	NULL
Sp1F	NULL
)	NULL
{	NULL
lane	NULL
2	NULL
)	NULL
;	NULL
SPIFJ	NULL
plus	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
;	NULL
SplF	NULL
]	NULL
plus	NULL
HMG-88	NULL
and	NULL
Ets-1	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
;	NULL
SpIF	NULL
]	NULL
)	NULL
plus	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
TFE-3	NULL
{	NULL
lane	NULL
5	NULL
)	NULL
;	NULL
or	NULL
SplF	NULL
)	NULL
J	NULL
plus	NULL
HMG-88	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
TFE-3	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

{	NULL
B	NULL
)	NULL
Comparison	NULL
of	NULL
the	NULL
DNA-binding	NULL
and	NULL
bending	NULL
activity	NULL
of	NULL
the	NULL
LEF-1	NULL
truncation	NULL
mutant	NULL
(	NULL
HMG-88	NULL
)	NULL
and	NULL
the	NULL
full-length	NULL
LEF-1	NULL
(	NULL
FL-hLEF	NULL
)	NULL
in	NULL
a	NULL
gel	NULL
mobility	NULL
shift	NULL
circular	NULL
permutation	NULL
assay	NULL
.	NULL

The	NULL
protein-DNA	NULL
complexes	NULL
generated	NULL
by	NULL
the	NULL
full-length	NULL
LEF-1	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
the	NULL
HMG-88	NULL
mutant	NULL
{	NULL
lane	NULL
10	NULL
)	NULL
were	NULL
specifically	NULL
competed	NULL
by	NULL
an	NULL
unlabeled	NULL
LEF-1~binding-site	NULL
oligonucleotide	NULL
[	NULL
lanes	NULL
3	NULL
and	NULL
11	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Fragments	NULL
prepared	NULL
by	NULL
digestion	NULL
with	NULL
different	NULL
restriction	NULL
endonucleases	NULL
that	NULL
shift	NULL
the	NULL
relative	NULL
location	NULL
of	NULL
the	NULL
LEF-1	NULL
binding	NULL
site	NULL
display	NULL
altered	NULL
electrophoretic	NULL
mobility	NULL
as	NULL
a	NULL
result	NULL
of	NULL
bending	NULL
by	NULL
either	NULL
the	NULL
FL-LEF-1	NULL
{	NULL
lanes	NULL
4-9	NULL
)	NULL
or	NULL
truncated	NULL
HMG-88	NULL
proteins	NULL
{	NULL
lanes	NULL
12-17	NULL
)	NULL
.	NULL

(	NULL
Lane	NULL
1	NULL
)	NULL
The	NULL
EcoRI-digested	NULL
DNA	NULL
fragment	NULL
without	NULL
LEF-1	NULL
.	NULL

Restriction	NULL
enzymes	NULL
used	NULL
were	NULL
EcoRI	NULL
(	NULL
RI	NULL
)	NULL
,	NULL
HindIII	NULL
(	NULL
H3	NULL
)	NULL
,	NULL
BstN1	NULL
(	NULL
Bs	NULL
)	NULL
,	NULL
EcoRV	NULL
(	NULL
RV	NULL
)	NULL
,	NULL
Nhel	NULL
(	NULL
N	NULL
}	NULL
,	NULL
and	NULL
BamHI	NULL
[	NULL
Bam	NULL
]	NULL
.	NULL

2098	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
for	NULL
the	NULL
full-length	NULL
LEF-1	NULL
protein	NULL
{	NULL
132°	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprint	NULL
experiments	NULL
on	NULL
the	NULL
chromatin-assembled	NULL
plasmids	NULL
revealed	NULL
further	NULL
that	NULL
the	NULL
LEF-1	NULL
and	NULL
HMG-88	NULL
proteins	NULL
bound	NULL
equivalently	NULL
to	NULL
the	NULL
distal	NULL
site	NULL
on	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
on	NULL
nucleosomal	NULL
DNA	NULL
(	NULL
P.	NULL
Sheridan	NULL
and	NULL
M.	NULL
Pazin	NULL
,	NULL
unpubl	NULL
.	NULL
)	NULL

.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
LEF-1	NULL
to	NULL
bend	NULL
and	NULL
wrap	NULL
DNA	NULL
through	NULL
the	NULL
HMG	NULL
domain	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
account	NULL
for	NULL
its	NULL
effects	NULL
on	NULL
nucleosomal	NULL
derepression	NULL
in	NULL
vitro	NULL
.	NULL

These	NULL
findings	NULL
also	NULL
confirm	NULL
the	NULL
results	NULL
obtained	NULL
in	NULL
transient	NULL
expression	NULL
assays	NULL
showing	NULL
that	NULL
the	NULL
trans-activation	NULL
domain	NULL
is	NULL
essential	NULL
for	NULL
activation	NULL
by	NULL
LEF-1	NULL
in	NULL
vivo	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
paper	NULL
we	NULL
define	NULL
the	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
as	NULL
a	NULL
functional	NULL
target	NULL
for	NULL
transcriptional	NULL
activation	NULL
by	NULL
the	NULL
LEF-1	NULL
HMG	NULL
protein	NULL
in	NULL
vivo	NULL
and	NULL
demonstrate	NULL
that	NULL
purified	NULL
recombinant	NULL
LEF-1	NULL
protein	NULL
strongly	NULL
activates	NULL
HIV-1	NULL
transcription	NULL
in	NULL
vitro	NULL
on	NULL
chromatin-assembled	NULL
DNA	NULL
.	NULL

Optimal	NULL
derepression	NULL
of	NULL
transcription	NULL
from	NULL
nucleosomal	NULL
HIV-1	NULL
DNA	NULL
required	NULL
a	NULL
combination	NULL
of	NULL
Spl	NULL
and	NULL
distal	NULL
enhancer-binding	NULL
proteins	NULL
.	NULL

Nucleosomal	NULL
derepression	NULL
was	NULL
found	NULL
to	NULL
require	NULL
the	NULL
LEF-1	NULL
trans-activation	NULL
domain	NULL
and	NULL
was	NULL
not	NULL
the	NULL
simple	NULL
consequence	NULL
of	NULL
the	NULL
bending	NULL
of	NULL
DNA	NULL
by	NULL
the	NULL
LEF-1	NULL
HMG	NULL
domain	NULL
.	NULL

These	NULL
results	NULL
have	NULL
specific	NULL
implications	NULL
for	NULL
the	NULL
mechanism	NULL
of	NULL
activation	NULL
by	NULL
LEF-1	NULL
and	NULL
also	NULL
provide	NULL
a	NULL
general	NULL
approach	NULL
that	NULL
can	NULL
be	NULL
used	NULL
to	NULL
investigate	NULL
the	NULL
events	NULL
leading	NULL
to	NULL
induction	NULL
of	NULL
HIV-1	NULL
transcription	NULL
from	NULL
promoters	NULL
integrated	NULL
into	NULL
nucleosomal	NULL
DNA	NULL
.	NULL

Regulation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
by	NULL
LEF-1	NULL
The	NULL
HIV-1	NULL
enhancer	NULL
meets	NULL
both	NULL
of	NULL
the	NULL
criteria	NULL
that	NULL
were	NULL
used	NULL
to	NULL
identify	NULL
the	NULL
TCRa	NULL
enhancer	NULL
as	NULL
a	NULL
target	NULL
for	NULL
activation	NULL
by	NULL
LEF-1	NULL
in	NULL
vivo	NULL
,	NULL
because	NULL
mutations	NULL
in	NULL
the	NULL
LEF-1	NULL
binding	NULL
site	NULL
reduce	NULL
HIV-1	NULL
enhancer	NULL
activity	NULL
and	NULL
a	NULL
GAL4-substituted	NULL
HIV-1	NULL
enhancer	NULL
was	NULL
strongly	NULL
induced	NULL
by	NULL
LEF-1/GAL4	NULL
in	NULL
activated	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
was	NULL
possible	NULL
to	NULL
demonstrate	NULL
a	NULL
requirement	NULL
for	NULL
the	NULL
LEF-1	NULL
and	NULL
Ets-1-binding	NULL
sites	NULL
on	NULL
multimerized	NULL
copies	NULL
of	NULL
the	NULL
minimal	NULL
HIV-1	NULL
enhancer	NULL
activity	NULL
in	NULL
transient	NULL
assays	NULL
,	NULL
comparable	NULL
mutations	NULL
have	NULL
much	NULL
more	NULL
modest	NULL
effects	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
entire	NULL
HIV-1	NULL
LTR	NULL
in	NULL
transient	NULL
assays	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
single	NULL
linker-scanning	NULL
mutation	NULL
of	NULL
the	NULL
-binding	NULL
site	NULL
in	NULL
the	NULL
intact	NULL
HIV-1	NULL
LTR	NULL
promoter	NULL
had	NULL
a	NULL
dramatic	NULL
effect	NULL
on	NULL
virus	NULL
replication	NULL
(	NULL
Kim	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
,	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
this	NULL
mutant	NULL
and	NULL
others	NULL
in	NULL
the	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
enhancer	NULL
was	NULL
much	NULL
more	NULL
pronounced	NULL
for	NULL
proviral	NULL
promoter	NULL
activity	NULL
than	NULL
for	NULL
promoter	NULL
activity	NULL
measured	NULL
in	NULL
transient	NULL
expression	NULL
assays	NULL
(	NULL
Zeichner	NULL
et	NULL
al	NULL
.	NULL

1991a	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
chromatin	NULL
templates	NULL
are	NULL
required	NULL
to	NULL
detect	NULL
activation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
by	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
in	NULL
vitro	NULL
,	NULL
these	NULL
studies	NULL
suggest	NULL
that	NULL
LEF-1	NULL
may	NULL
be	NULL
particularly	NULL
important	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
promoters	NULL
that	NULL
have	NULL
been	NULL
stably	NULL
integrated	NULL
into	NULL
the	NULL
genome	NULL
and	NULL
assembled	NULL
into	NULL
chromatin	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
the	NULL
arrangement	NULL
of	NULL
transcription	NULL
fac-	NULL
Chromatin-dependent	NULL
trans-activation	NULL
by	NULL
LEF-1	NULL
tor-binding	NULL
sites	NULL
within	NULL
the	NULL
HIV-1	NULL
and	NULL
TCRa	NULL
enhancers	NULL
reveals	NULL
two	NULL
similar	NULL
underlying	NULL
features	NULL
that	NULL
may	NULL
be	NULL
critical	NULL
for	NULL
activation	NULL
by	NULL
LEF-1	NULL
.	NULL

Specifically	NULL
,	NULL
in	NULL
each	NULL
enhancer	NULL
the	NULL
LEF-1-binding	NULL
site	NULL
lies	NULL
between	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
a	NULL
strong	NULL
and	NULL
inducible	NULL
activator	NULL
[	NULL
NF-	NULL
«	NULL
B	NULL
for	NULL
HIV-1	NULL
,	NULL
and	NULL
CAMP	NULL
response	NULL
element-binding	NULL
(	NULL
{	NULL
protein	NULL
)	NULL
/activat-ing	NULL
transcription	NULL
factor	NULL
(	NULL
CREB/ATF	NULL
)	NULL
on	NULL
the	NULL
TCRa	NULL
«	NULL
en-hancer	NULL
]	NULL
and	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
lymphoid-specific	NULL
protein	NULL
,	NULL
Ets-1	NULL
.	NULL

Additional	NULL
factors	NULL
bound	NULL
near	NULL
the	NULL
Ets-1	NULL
site	NULL
on	NULL
each	NULL
enhancer	NULL
{	NULL
(	NULL
PEBP2	NULL
for	NULL
TCRa	NULL
and	NULL
TFE-3	NULL
for	NULL
HIV-1	NULL
)	NULL
enhance	NULL
the	NULL
binding	NULL
of	NULL
Ets-1	NULL
to	NULL
DNA	NULL
in	NULL
vitro	NULL
(	NULL
Giese	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
;	NULL
M.	NULL
Voz	NULL
,	NULL
C.	NULL
Sheline	NULL
,	NULL
and	NULL
K.	NULL
Jones	NULL
,	NULL
unpubl	NULL
.	NULL
}	NULL

,	NULL
and	NULL
at	NULL
least	NULL
in	NULL
the	NULL
case	NULL
of	NULL
TFE-3	NULL
,	NULL
can	NULL
also	NULL
independently	NULL
activate	NULL
transcription	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
Ets-l-binding	NULL
site	NULL
seemed	NULL
to	NULL
contribute	NULL
to	NULL
HIV-1	NULL
enhancer	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
only	NULL
when	NULL
positioned	NULL
adjacent	NULL
to	NULL
a	NULL
functional	NULL
binding	NULL
site	NULL
for	NULL
LEF-1	NULL
,	NULL
indicating	NULL
that	NULL
LEF-1	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
ability	NULL
of	NULL
Ets-1	NULL
to	NULL
stimulate	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
.	NULL

A	NULL
similar	NULL
interplay	NULL
between	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
was	NULL
observed	NULL
previously	NULL
with	NULL
the	NULL
TCRa	NULL
enhancer	NULL
(	NULL
Carlsson	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
;	NULL
Giese	NULL
and	NULL
Grosschedl	NULL
1993	NULL
)	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
,	NULL
it	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
learn	NULL
whether	NULL
other	NULL
LEF-responsive	NULL
enhancers	NULL
in	NULL
T	NULL
cells	NULL
share	NULL
the	NULL
requirement	NULL
for	NULL
a	NULL
nearby	NULL
Ets-1-binding	NULL
site	NULL
.	NULL

Synergistic	NULL
activation	NULL
of	NULL
transcription	NULL
in	NULL
vitro	NULL
by	NULL
multiple	NULL
proteins	NULL
bound	NULL
to	NULL
chromatin-assembled	NULL
HIV-1	NULL
DNA	NULL
It	NULL
is	NULL
interesting	NULL
that	NULL
a	NULL
combination	NULL
of	NULL
Spl	NULL
and	NULL
multiple	NULL
distal	NULL
enhancer-binding	NULL
proteins	NULL
was	NULL
required	NULL
to	NULL
derepress	NULL
HIV-1	NULL
transcription	NULL
in	NULL
chromatin	NULL
reconstitution	NULL
experiments	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
saturating	NULL
amounts	NULL
of	NULL
individual	NULL
factors	NULL
.	NULL

Thus	NULL
,	NULL
neither	NULL
the	NULL
enhancer-binding	NULL
proteins	NULL
nor	NULL
Spl	NULL
were	NULL
capable	NULL
of	NULL
acting	NULL
on	NULL
their	NULL
own	NULL
to	NULL
induce	NULL
significant	NULL
levels	NULL
of	NULL
transcription	NULL
from	NULL
chromatin	NULL
.	NULL

Preincubation	NULL
of	NULL
the	NULL
DNA	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
Spl	NULL
and	NULL
the	NULL
TBP	NULL
,	NULL
or	NULL
even	NULL
Sp1	NULL
,	NULL
TBP	NULL
,	NULL
and	NULL
the	NULL
general	NULL
transcription	NULL
factor	NULL
TFIIB	NULL
,	NULL
also	NULL
failed	NULL
to	NULL
generate	NULL
high	NULL
levels	NULL
of	NULL
transcription	NULL
in	NULL
these	NULL
assays	NULL
[	NULL
(	NULL
P.	NULL
Sheridan	NULL
and	NULL
C.	NULL
George	NULL
,	NULL
unpubl	NULL
.	NULL
)	NULL

.	NULL

Instead	NULL
,	NULL
in	NULL
vitro	NULL
transcription	NULL
on	NULL
HIV-1	NULL
chromatin	NULL
was	NULL
found	NULL
to	NULL
require	NULL
both	NULL
promoter	NULL
and	NULL
enhancer-binding	NULL
proteins	NULL
.	NULL

Because	NULL
Spl	NULL
is	NULL
present	NULL
in	NULL
the	NULL
HeLa	NULL
nuclear	NULL
transcription	NULL
extract	NULL
that	NULL
is	NULL
added	NULL
after	NULL
nucleosome	NULL
assembly	NULL
,	NULL
it	NULL
is	NULL
not	NULL
evident	NULL
why	NULL
Spl	NULL
should	NULL
need	NULL
to	NULL
be	NULL
added	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
enhancer	NULL
factors	NULL
to	NULL
derepress	NULL
nucleosomal	NULL
templates	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
optimal	NULL
activation	NULL
by	NULL
Spl	NULL
may	NULL
require	NULL
that	NULL
it	NULL
bind	NULL
DNA	NULL
cooperatively	NULL
with	NULL
the	NULL
enhancer	NULL
factors	NULL
.	NULL

Alternatively	NULL
,	NULL
Spl	NULL
may	NULL
function	NULL
best	NULL
when	NULL
bound	NULL
to	NULL
DNA	NULL
prior	NULL
to	NULL
the	NULL
process	NULL
of	NULL
chromatin	NULL
assembly	NULL
.	NULL

Although	NULL
LEF-1	NULL
and	NULL
Ets-l	NULL
were	NULL
found	NULL
to	NULL
stimulate	NULL
transcription	NULL
on	NULL
nucleosomal	NULL
DNA	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
detect	NULL
activation	NULL
of	NULL
naked	NULL
DNA	NULL
templates	NULL
by	NULL
either	NULL
protein	NULL
.	NULL

Similarly	NULL
,	NULL
mutations	NULL
in	NULL
the	NULL
LEF-l-binding	NULL
site	NULL
in	NULL
the	NULL
HIV-1	NULL
promoter	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
transcription	NULL
of	NULL
naked	NULL
DNA	NULL
in	NULL
Jurkat	NULL
T	NULL
cell	NULL
extracts	NULL
that	NULL
contain	NULL
the	NULL
endogeneous	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
proteins	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
a	NULL
chromatin	NULL
template	NULL
is	NULL
required	NULL
to	NULL
study	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
by	NULL
LEF-1	NULL
in	NULL
vitro	NULL
.	NULL

Several	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
2099	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Sheridan	NULL
et	NULL
al	NULL
.	NULL

recent	NULL
studies	NULL
have	NULL
documented	NULL
dramatic	NULL
effects	NULL
of	NULL
chromatin	NULL
on	NULL
enhancer	NULL
activity	NULL
in	NULL
vitro	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
degree	NULL
of	NULL
activation	NULL
by	NULL
enhancer-binding	NULL
proteins	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
several	NULL
orders	NULL
of	NULL
magnitude	NULL
stronger	NULL
on	NULL
chromatin	NULL
than	NULL
on	NULL
naked	NULL
DNA	NULL
,	NULL
and	NULL
nucleosomal	NULL
templates	NULL
have	NULL
been	NULL
found	NULL
to	NULL
be	NULL
absolutely	NULL
required	NULL
for	NULL
long-range	NULL
activation	NULL
from	NULL
distal	NULL
enhancer	NULL
elements	NULL
in	NULL
vitro	NULL
(	NULL
Laybourn	NULL
and	NULL
Kadonaga	NULL
1991	NULL
,	NULL
1992	NULL
;	NULL
Barton	NULL
and	NULL
Emerson	NULL
1994	NULL
}	NULL
.	NULL

More	NULL
complex	NULL
,	NULL
qualitative	NULL
differences	NULL
in	NULL
transcriptional	NULL
activity	NULL
have	NULL
also	NULL
been	NULL
observed	NULL
in	NULL
studies	NULL
comparing	NULL
transcription	NULL
on	NULL
chromatin	NULL
and	NULL
nonchromatin	NULL
DNA	NULL
templates	NULL
in	NULL
vitro	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
VP16	NULL
trans-activation	NULL
domain	NULL
in	NULL
the	NULL
GAL4/VP16	NULL
fusion	NULL
protein	NULL
was	NULL
found	NULL
not	NULL
to	NULL
be	NULL
required	NULL
for	NULL
stimulation	NULL
of	NULL
transcription	NULL
from	NULL
naked	NULL
DNA	NULL
but	NULL
was	NULL
essential	NULL
for	NULL
transcription	NULL
of	NULL
chromatin	NULL
templates	NULL
(	NULL
Pazin	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
chick	NULL
B-globin	NULL
promoter	NULL
through	NULL
a	NULL
GATA	NULL
motif	NULL
positioned	NULL
at	NULL
-	NULL
30	NULL
in	NULL
the	NULL
promoter	NULL
was	NULL
found	NULL
to	NULL
be	NULL
inappropriately	NULL
stimulated	NULL
by	NULL
TBP	NULL
on	NULL
naked	NULL
DNA	NULL
templates	NULL
,	NULL
whereas	NULL
only	NULL
the	NULL
erythroid-specific	NULL
GATA-1	NULL
enhancer	NULL
factor	NULL
could	NULL
activate	NULL
this	NULL
element	NULL
on	NULL
nucleosomal	NULL
DNA	NULL
in	NULL
vitro	NULL
(	NULL
Fong	NULL
and	NULL
Emerson	NULL
1992	NULL
;	NULL
Barton	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

In	NULL
each	NULL
of	NULL
these	NULL
examples	NULL
,	NULL
transcription	NULL
from	NULL
chromatin	NULL
in	NULL
vitro	NULL
more	NULL
accurately	NULL
reflects	NULL
the	NULL
parameters	NULL
of	NULL
activation	NULL
observed	NULL
in	NULL
vivo	NULL
than	NULL
does	NULL
transcription	NULL
of	NULL
naked	NULL
DNA	NULL
templates	NULL
.	NULL

Whereas	NULL
the	NULL
mechanisms	NULL
responsible	NULL
for	NULL
the	NULL
unique	NULL
effects	NULL
of	NULL
chromatin	NULL
on	NULL
transcription	NULL
have	NULL
not	NULL
been	NULL
iden-tified	NULL
,	NULL
they	NULL
may	NULL
involve	NULL
the	NULL
action	NULL
of	NULL
proteins	NULL
that	NULL
are	NULL
specifically	NULL
required	NULL
to	NULL
transcribe	NULL
chromatin	NULL
.	NULL

For	NULL
example	NULL
,	NULL
transcription	NULL
on	NULL
chromatin	NULL
might	NULL
require	NULL
factors	NULL
that	NULL
have	NULL
been	NULL
implicated	NULL
to	NULL
play	NULL
a	NULL
specialized	NULL
role	NULL
for	NULL
enhancer-driven	NULL
transcription	NULL
in	NULL
vivo	NULL
,	NULL
such	NULL
as	NULL
the	NULL
proteins	NULL
associated	NULL
with	NULL
the	NULL
holoenzyme	NULL
form	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
(	NULL
Kelleher	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
;	NULL
Koleske	NULL
and	NULL
Young	NULL
1995	NULL
]	NULL
or	NULL
the	NULL
carboxy-terminal	NULL
domain	NULL
{	NULL
(	NULL
CTD	NULL
)	NULL
of	NULL
the	NULL
large	NULL
sub-unit	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
(	NULL
Gerber	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
]	NULL
.	NULL

Bending	NULL
of	NULL
DNA	NULL
by	NULL
the	NULL
HMG	NULL
domain	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
counteract	NULL
chromatin	NULL
repression	NULL
in	NULL
vitro	NULL
:	NULL
Implications	NULL
for	NULL
the	NULL
mechanism	NULL
of	NULL
LEF-1	NULL
activation	NULL
Similarly	NULL
to	NULL
other	NULL
HMG	NULL
proteins	NULL
,	NULL
LEF-1	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
play	NULL
an	NULL
architectural	NULL
role	NULL
in	NULL
transcription	NULL
in	NULL
which	NULL
bending	NULL
of	NULL
DNA	NULL
by	NULL
the	NULL
HMG	NULL
box	NULL
is	NULL
proposed	NULL
to	NULL
promote	NULL
interactions	NULL
between	NULL
adjacent	NULL
DNA-binding	NULL
proteins	NULL
and	NULL
thereby	NULL
facilitate	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
multiprotein	NULL
complex	NULL
at	NULL
the	NULL
enhancer	NULL
(	NULL
Giese	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
;	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Grosschedl	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
;	NULL
Tjian	NULL
and	NULL
Maniatis	NULL
1994	NULL
)	NULL
.	NULL

By	NULL
analogy	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
LEF-1	NULL
to	NULL
bend	NULL
DNA	NULL
could	NULL
facilitate	NULL
interactions	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Ets-1	NULL
or	NULL
other	NULL
proteins	NULL
bound	NULL
to	NULL
distal	NULL
regions	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
.	NULL

However	NULL
,	NULL
two	NULL
lines	NULL
of	NULL
evidence	NULL
indicate	NULL
that	NULL
LEF-1	NULL
activation	NULL
of	NULL
both	NULL
the	NULL
TCRa	NULL
and	NULL
HIV-1	NULL
enhancers	NULL
is	NULL
more	NULL
complex	NULL
than	NULL
that	NULL
suggested	NULL
by	NULL
simple	NULL
DNA-bending	NULL
models	NULL
.	NULL

First	NULL
,	NULL
activation	NULL
of	NULL
either	NULL
the	NULL
TCRa	NULL
or	NULL
HIV-1	NULL
enhancers	NULL
by	NULL
LEF-1	NULL
in	NULL
B	NULL
cells	NULL
requires	NULL
the	NULL
LEF-1	NULL
trans-activation	NULL
domain	NULL
(	NULL
Carlsson	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
;	NULL
other	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
we	NULL
show	NULL
here	NULL
that	NULL
a	NULL
mutant	NULL
LEF-1	NULL
2100	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
protein	NULL
{	NULL
[	NULL
HMG-88	NULL
)	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
HMG	NULL
domain	NULL
but	NULL
lacks	NULL
the	NULL
activation	NULL
domain	NULL
,	NULL
does	NULL
not	NULL
stimulate	NULL
HIV-1	NULL
transcription	NULL
on	NULL
chromatin	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
it	NULL
binds	NULL
and	NULL
bends	NULL
DNA	NULL
as	NULL
avidly	NULL
as	NULL
the	NULL
full-length	NULL
LEF-1	NULL
protein	NULL
in	NULL
vitro	NULL
[	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
if	NULL
LEF-1	NULL
were	NULL
to	NULL
function	NULL
principally	NULL
to	NULL
bend	NULL
DNA	NULL
and	NULL
facilitate	NULL
interactions	NULL
between	NULL
NF-KB	NULL
and	NULL
more	NULL
distal	NULL
HIV-1	NULL
enhancer-binding	NULL
proteins	NULL
,	NULL
we	NULL
would	NULL
have	NULL
expected	NULL
that	NULL
LEF-1	NULL
activity	NULL
would	NULL
require	NULL
NF-kB	NULL
in	NULL
vitro	NULL
.	NULL

Yet	NULL
the	NULL
transcription	NULL
experiments	NULL
reported	NULL
here	NULL
reveal	NULL
that	NULL
LEF-1	NULL
and	NULL
Ets-l1	NULL
can	NULL
activate	NULL
HIV-1	NULL
transcription	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
a	NULL
finding	NULL
consistent	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
mutations	NULL
of	NULL
the	NULL
NF-kB	NULL
sites	NULL
reduce	NULL
overall	NULL
enhancer	NULL
activity	NULL
but	NULL
do	NULL
not	NULL
destroy	NULL
activation	NULL
by	NULL
LEF-1/GAL4	NULL
in	NULL
vivo	NULL
[	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
determined	NULL
that	NULL
the	NULL
LEF-1	NULL
activation	NULL
domain	NULL
is	NULL
also	NULL
required	NULL
when	NULL
NF-kB	NULL
is	NULL
present	NULL
in	NULL
the	NULL
reaction	NULL
[	NULL
P.	NULL
Sheridan	NULL
and	NULL
M.	NULL
Pazin	NULL
,	NULL
unpubl	NULL
.	NULL
)	NULL

.	NULL

Therefore	NULL
LEF-1	NULL
can	NULL
enhance	NULL
transcription	NULL
in	NULL
an	NULL
activation	NULL
domain-depen-dent	NULL
manner	NULL
without	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
any	NULL
model	NULL
for	NULL
LEF-1	NULL
activity	NULL
must	NULL
incorporate	NULL
the	NULL
role	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
as	NULL
well	NULL
as	NULL
an	NULL
explanation	NULL
of	NULL
the	NULL
cooperative	NULL
effects	NULL
of	NULL
LEF-1	NULL
and	NULL
Ets-l1	NULL
on	NULL
transcription	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NF-KB	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
described	NULL
here	NULL
will	NULL
be	NULL
useful	NULL
to	NULL
assess	NULL
the	NULL
relative	NULL
activities	NULL
of	NULL
different	NULL
members	NULL
of	NULL
the	NULL
multigene	NULL
LEF	NULL
and	NULL
ETS	NULL
protein	NULL
families	NULL
and	NULL
to	NULL
define	NULL
domains	NULL
of	NULL
these	NULL
proteins	NULL
that	NULL
are	NULL
needed	NULL
to	NULL
activate	NULL
chromatin	NULL
templates	NULL
.	NULL

This	NULL
approach	NULL
will	NULL
also	NULL
be	NULL
informative	NULL
for	NULL
studies	NULL
on	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
LEF-1	NULL
activates	NULL
the	NULL
TCRa	NULL
enhancer	NULL
and	NULL
other	NULL
responsive	NULL
enhancers	NULL
.	NULL

Although	NULL
LEF-1	NULL
is	NULL
found	NULL
only	NULL
in	NULL
lymphoid	NULL
tissues	NULL
in	NULL
the	NULL
adult	NULL
,	NULL
it	NULL
is	NULL
expressed	NULL
relatively	NULL
ubiquitously	NULL
at	NULL
early	NULL
stages	NULL
of	NULL
mouse	NULL
development	NULL
(	NULL
Oosterwe-gel	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
;	NULL
van	NULL
Genderen	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
)	NULL
,	NULL
and	NULL
gene	NULL
disruption	NULL
and	NULL
misexpression	NULL
experiments	NULL
in	NULL
transgenic	NULL
mice	NULL
have	NULL
revealed	NULL
that	NULL
LEF-1	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
normal	NULL
development	NULL
of	NULL
hair	NULL
follicles	NULL
and	NULL
tooth	NULL
buds	NULL
(	NULL
van	NULL
Genderen	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
;	NULL
Zhou	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
it	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
learn	NULL
whether	NULL
the	NULL
functional	NULL
targets	NULL
for	NULL
LEF-1	NULL
in	NULL
the	NULL
skin	NULL
and	NULL
hair	NULL
,	NULL
including	NULL
kerati-nocyte	NULL
hair-specific	NULL
promoters	NULL
that	NULL
contain	NULL
multiple	NULL
LEF-1l-binding	NULL
sites	NULL
(	NULL
Zhou	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
)	NULL
,	NULL
are	NULL
activated	NULL
by	NULL
mechanisms	NULL
similar	NULL
to	NULL
those	NULL
characterized	NULL
for	NULL
the	NULL
HIV-1	NULL
and	NULL
TCRa	NULL
enhancers	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
our	NULL
results	NULL
indicate	NULL
that	NULL
LEF-1	NULL
and	NULL
Ets-1	NULL
preferentially	NULL
activate	NULL
HIV-1	NULL
transcription	NULL
from	NULL
chromatin	NULL
templates	NULL
in	NULL
vitro	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
,	NULL
methods	NULL
that	NULL
monitor	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
from	NULL
stably	NULL
integrated	NULL
DNA	NULL
or	NULL
in	NULL
transgenic	NULL
animals	NULL
may	NULL
be	NULL
required	NULL
to	NULL
observe	NULL
a	NULL
requirement	NULL
for	NULL
LEF-1	NULL
in	NULL
vivo	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
transcription	NULL
on	NULL
nucleosomal	NULL
HIV-1	NULL
DNA	NULL
templates	NULL
is	NULL
enhancer-dependent	NULL
and	NULL
sensitive	NULL
to	NULL
the	NULL
combinatorial	NULL
effects	NULL
of	NULL
several	NULL
different	NULL
classes	NULL
of	NULL
enhancer-binding	NULL
proteins	NULL
.	NULL

As	NULL
packaging	NULL
of	NULL
the	NULL
DNA	NULL
template	NULL
into	NULL
chromatin	NULL
can	NULL
have	NULL
profound	NULL
effects	NULL
on	NULL
both	NULL
RNA	NULL
initiation	NULL
(	NULL
Felsenfeld	NULL
1992	NULL
;	NULL
Adams	NULL
and	NULL
Workman	NULL
1993	NULL
;	NULL
Paranjape	NULL
et	NULL
al	NULL
,	NULL
1994	NULL
)	NULL
and	NULL
elongation	NULL
[	NULL
Izban	NULL
and	NULL
Luse	NULL
1991	NULL
)	NULL
,	NULL
an	NULL
expansion	NULL
of	NULL
this	NULL
approach	NULL
to	NULL
include	NULL
other	NULL
regulatory	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
NF-kB	NULL
,	NULL
LBP-1	NULL
,	NULL
and	NULL
the	NULL
virus-encoded	NULL
Tat	NULL
protein	NULL
,	NULL
should	NULL
generate	NULL
a	NULL
useful	NULL
sys-	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
tem	NULL
with	NULL
which	NULL
to	NULL
model	NULL
the	NULL
events	NULL
leading	NULL
to	NULL
expression	NULL
of	NULL
the	NULL
integrated	NULL
HIV-1	NULL
provirus	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Construction	NULL
of	NULL
HIV-1	NULL
enhancer	NULL
mutants	NULL
and	NULL
transient	NULL
expression	NULL
assays	NULL
The	NULL
mutant	NULL
enhancers	NULL
were	NULL
constructed	NULL
into	NULL
the	NULL
vector	NULL
HIV-1/LUC	NULL
by	NULL
a	NULL
two-step	NULL
PCR	NULL
mutagenesis	NULL
procedure	NULL
designed	NULL
to	NULL
alter	NULL
sequences	NULL
between	NULL
-340	NULL
and	NULL
+80	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
.	NULL

The	NULL
LM	NULL
contained	NULL
a	NULL
4-bp	NULL
substitution	NULL
of	NULL
the	NULL
distal	NULL
LEF-1	NULL
site	NULL
replacing	NULL
the	NULL
wild-type	NULL
sequence	NULL
with	NULL
5'-TGTCGAT-3	NULL
'	NULL
;	NULL
the	NULL
Ets-1	NULL
mutant	NULL
DNA	NULL
contained	NULL
a	NULL
5-bp	NULL
substitution	NULL
changing	NULL
the	NULL
wild-type	NULL
sequence	NULL
to	NULL
5'-CCTCTACC-3	NULL
'	NULL
;	NULL
and	NULL
the	NULL
E-box	NULL
mutant	NULL
was	NULL
deleted	NULL
of	NULL
sequences	NULL
upstream	NULL
of	NULL
-163	NULL
.	NULL

The	NULL
GAL4-substituted	NULL
HIV-1	NULL
enhancer	NULL
replaced	NULL
the	NULL
LEF-l-binding	NULL
site	NULL
domain	NULL
,	NULL
5-	NULL
AGCAG-CAGTCTTTGTA-3	NULL
'	NULL
with	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
GAL4	NULL
DNA-binding	NULL
site	NULL
,	NULL
5-CGGAGTACTGTCCTCCG-3	NULL
'	NULL
.	NULL

To	NULL
test	NULL
the	NULL
effects	NULL
of	NULL
these	NULL
mutations	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
,	NULL
DNA	NULL
fragments	NULL
containing	NULL
the	NULL
minimal	NULL
enhancer	NULL
unit	NULL
(	NULL
-81	NULL
to	NULL
-177	NULL
)	NULL
were	NULL
subcloned	NULL
at	NULL
a	NULL
position	NULL
76	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
of	NULL
the	NULL
HSV-1	NULL
tk	NULL
promoter	NULL
in	NULL
a	NULL
luciferase	NULL
vector	NULL
.	NULL

Constructs	NULL
containing	NULL
single	NULL
and	NULL
tandem	NULL
head-to-tail	NULL
inserts	NULL
were	NULL
isolated	NULL
,	NULL
and	NULL
the	NULL
sequence	NULL
of	NULL
all	NULL
of	NULL
the	NULL
enhancer	NULL
constructs	NULL
was	NULL
confirmed	NULL
by	NULL
dideoxynucleotide	NULL
sequencing	NULL
.	NULL

Transient	NULL
expression	NULL
assays	NULL
were	NULL
performed	NULL
by	NULL
electroporation	NULL
of	NULL
2	NULL
ug	NULL
of	NULL
HIV-1/LUC	NULL
DNA	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
pCMV/CAT	NULL
,	NULL
and	NULL
10	NULL
mg	NULL
of	NULL
carrier	NULL
DNA	NULL
or	NULL
LEF-1/GAL4	NULL
DNA	NULL
(	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
into	NULL
Jurkat	NULL
cells	NULL
that	NULL
were	NULL
activated	NULL
by	NULL
treatment	NULL
for	NULL
15	NULL
hr	NULL
with	NULL
50	NULL
ng/ml	NULL
of	NULL
TPA	NULL
.	NULL

Luciferase	NULL
activity	NULL
from	NULL
each	NULL
construct	NULL
was	NULL
normalized	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
pCMV/CAT	NULL
,	NULL
which	NULL
was	NULL
included	NULL
in	NULL
each	NULL
experiment	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
,	NULL
and	NULL
the	NULL
numbers	NULL
listed	NULL
in	NULL
Figure	NULL
2	NULL
are	NULL
the	NULL
average	NULL
of	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
transfection	NULL
experiments	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
The	NULL
DNase	NULL
I	NULL
footprint	NULL
probe	NULL
was	NULL
labeled	NULL
at	NULL
+80	NULL
following	NULL
digestion	NULL
of	NULL
the	NULL
pLTR/CATAH3	NULL
plasmid	NULL
with	NULL
HindIII	NULL
DNA-binding	NULL
reactions	NULL
{	NULL
50	NULL
pl	NULL
final	NULL
volume	NULL
)	NULL
contained	NULL
300	NULL
pg	NULL
of	NULL
labeled	NULL
DNA	NULL
in	NULL
a	NULL
final	NULL
buffer	NULL
concentration	NULL
of	NULL
12.5	NULL
mm	NULL
HEPES	NULL
[	NULL
pH	NULL
7.6	NULL
)	NULL
,	NULL
6	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
50-120	NULL
mm	NULL
KCl	NULL
,	NULL
1	NULL
mm	NULL
DTT	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
3	NULL
%	NULL
polyvinyl	NULL
alcohol	NULL
(	NULL
type	NULL
II	NULL
,	NULL
low	NULL
mol	NULL
.	NULL

wt	NULL
.	NULL

,	NULL
Sigma	NULL
)	NULL
.	NULL

As	NULL
indicated	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Figure	NULL
1	NULL
,	NULL
reactions	NULL
contained	NULL
either	NULL
150	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
,	NULL
or	NULL
purified	NULL
recombinant	NULL
LEF-1	NULL
(	NULL
60	NULL
ng	NULL
}	NULL
,	NULL
GST/Ets-1	NULL
(	NULL
800	NULL
ng	NULL
)	NULL
,	NULL
or	NULL
TFE-3	NULL
{	NULL
10	NULL
ng	NULL
)	NULL
.	NULL

Footprint	NULL
reactions	NULL
were	NULL
catried	NULL
out	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
by	NULL
Waterman	NULL
and	NULL
Jones	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
recombinant	NULL
enhancer-binding	NULL
proteins	NULL
Full-length	NULL
human	NULL
LEF-1	NULL
{	NULL
LEF-1	NULL
)	NULL
and	NULL
HMG-88	NULL
clones	NULL
were	NULL
expressed	NULL
and	NULL
solubilized	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Waterman	NULL
et	NULL
al	NULL
.	NULL

1991	NULL
)	NULL
.	NULL

The	NULL
dialyzed	NULL
LEF-1	NULL
proteins	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
3-ml	NULL
heparin-agarose	NULL
column	NULL
equilibrated	NULL
in	NULL
TM	NULL
0.1	NULL
m	NULL
buffer	NULL
(	NULL
50	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
12.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
2	NULL
mm	NULL
DTT	NULL
,	NULL
0.1	NULL
mm	NULL
PMSF	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
containing	NULL
100	NULL
mm	NULL
KCI	NULL
)	NULL
.	NULL

A	NULL
15-ml	NULL
gradient	NULL
from	NULL
0.1	NULL
to	NULL
0.6	NULL
m	NULL
KCl	NULL
was	NULL
applied	NULL
,	NULL
and	NULL
the	NULL
LEF-1	NULL
and	NULL
HMG-88	NULL
proteins	NULL
eluted	NULL
at	NULL
~0.3	NULL
M	NULL
KCI	NULL
.	NULL

The	NULL
peak	NULL
of	NULL
protein	NULL
was	NULL
pooled	NULL
,	NULL
dialyzed	NULL
against	NULL
buffer	NULL
H	NULL
0.1	NULL
m	NULL
KCI	NULL
(	NULL
25	NULL
mm	NULL
HEPES	NULL
at	NULL
pH	NULL
7.6	NULL
,	NULL
12.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
2	NULL
mm	NULL
DTT	NULL
,	NULL
0.1	NULL
mm	NULL
PMSF	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
containing	NULL
100	NULL
mm	NULL
KCI	NULL
)	NULL
and	NULL
applied	NULL
to	NULL
a	NULL
fast	NULL
protein	NULL
liquid	NULL
Chromatin-dependent	NULL
trans-activation	NULL
by	NULL
LEF-1	NULL
chromatography	NULL
(	NULL
FPLC	NULL
)	NULL
Mono-S	NULL
column	NULL
equilibrated	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
.	NULL

A	NULL
15-ml	NULL
gradient	NULL
from	NULL
0.25	NULL
to	NULL
0.45	NULL
m	NULL
KCl	NULL
was	NULL
applied	NULL
and	NULL
LEF-1	NULL
and	NULL
HMG-88	NULL
eluted	NULL
at	NULL
~0.3-0.35	NULL
m	NULL
KCl	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
full-length	NULL
human	NULL
TFE-3	NULL
protein	NULL
was	NULL
expressed	NULL
as	NULL
a	NULL
native	NULL
(	NULL
nonfusion	NULL
)	NULL
protein	NULL
in	NULL
pET	NULL
-11d	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
K.	NULL
Murre	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Diego	NULL
)	NULL
and	NULL
was	NULL
present	NULL
in	NULL
the	NULL
soluble	NULL
fraction	NULL
after	NULL
centrifugation	NULL
of	NULL
the	NULL
bacterial	NULL
cell	NULL
lysate	NULL
.	NULL

The	NULL
TFE-3-containing	NULL
extracts	NULL
were	NULL
dialyzed	NULL
into	NULL
buffer	NULL
H	NULL
(	NULL
25	NULL
mm	NULL
HEPES	NULL
at	NULL
pH	NULL
8	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
mm	NULL
DTT	NULL
,	NULL
and	NULL
0.1	NULL
mm	NULL
PMSF	NULL
)	NULL
containing	NULL
0.3	NULL
m	NULL
KCI	NULL
,	NULL
and	NULL
passed	NULL
over	NULL
a	NULL
DEAE-Sepharose	NULL
column	NULL
{	NULL
3	NULL
ml	NULL
)	NULL
to	NULL
remove	NULL
polynucleotides	NULL
.	NULL

The	NULL
flowthrough	NULL
fraction	NULL
from	NULL
the	NULL
DEAE	NULL
column	NULL
was	NULL
diluted	NULL
with	NULL
two	NULL
volumes	NULL
of	NULL
TM	NULL
0	NULL
m	NULL
KCl	NULL
buffer	NULL
and	NULL
loaded	NULL
directly	NULL
onto	NULL
a	NULL
heparin-agarose	NULL
column	NULL
(	NULL
3	NULL
ml	NULL
)	NULL
equilibrated	NULL
in	NULL
TM	NULL
0.1	NULL
m	NULL
KCl	NULL
A	NULL
15-ml	NULL
gradient	NULL
of	NULL
TM	NULL
buffer	NULL
containing	NULL
from	NULL
0.1	NULL
to	NULL
0.6	NULL
m	NULL
KC	NULL
]	NULL
was	NULL
applied	NULL
,	NULL
and	NULL
the	NULL
TFE-3	NULL
protein	NULL
eluted	NULL
around	NULL
0.3	NULL
m	NULL
KC	NULL
]	NULL
.	NULL

The	NULL
peak	NULL
of	NULL
TFE-3	NULL
protein	NULL
was	NULL
pooled	NULL
,	NULL
dialyzed	NULL
against	NULL
TGED	NULL
0.1	NULL
m	NULL
KCI	NULL
buffer	NULL
(	NULL
50	NULL
mm	NULL
Tris-HCl	NULL
at	NULL
pH	NULL
7.9	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
2	NULL
mm	NULL
DTT	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
mm	NULL
PMSF	NULL
,	NULL
containing	NULL
100	NULL
mm	NULL
KCI	NULL
}	NULL
,	NULL
and	NULL
applied	NULL
to	NULL
an	NULL
FPLC	NULL
Mono	NULL
Q	NULL
column	NULL
equilibrated	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
.	NULL

A	NULL
15-ml	NULL
gradient	NULL
from	NULL
0.1	NULL
to	NULL
0.6	NULL
m	NULL
KCI	NULL
was	NULL
applied	NULL
and	NULL
TFE-3	NULL
protein	NULL
was	NULL
found	NULL
to	NULL
elute	NULL
at	NULL
0.28	NULL
m	NULL
KCL	NULL
.	NULL

The	NULL
full-length	NULL
human	NULL
Ets-l	NULL
cDNA	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
J.M	NULL
.	NULL

Leiden	NULL
,	NULL
University	NULL
of	NULL
Chicago	NULL
,	NULL
IL	NULL
]	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
pGST-ag	NULL
vector	NULL
,	NULL
expressed	NULL
as	NULL
a	NULL
glutathione	NULL
S-transferase	NULL
fusion	NULL
protein	NULL
,	NULL
and	NULL
purified	NULL
as	NULL
described	NULL
by	NULL
Ron	NULL
and	NULL
Dressler	NULL
(	NULL
1992	NULL
)	NULL
using	NULL
commercially	NULL
available	NULL
glutathione	NULL
,	NULL
Sepharose-4B	NULL
affinity	NULL
resin	NULL
(	NULL
Pharmacia	NULL
}	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
all	NULL
of	NULL
the	NULL
recombinant	NULL
proteins	NULL
was	NULL
tested	NULL
by	NULL
SDS-PAGE	NULL
[	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
transcription	NULL
extracts	NULL
and	NULL
purification	NULL
of	NULL
Sp1	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
human	NULL
Jurkat	NULL
and	NULL
Hela-S3	NULL
cell	NULL
lines	NULL
as	NULL
described	NULL
by	NULL
Waterman	NULL
and	NULL
Jones	NULL
(	NULL
1990	NULL
}	NULL
.	NULL

Briefly	NULL
,	NULL
12	NULL
liters	NULL
of	NULL
Jurkat	NULL
{	NULL
1.5	NULL
x	NULL
105/ml	NULL
}	NULL
or	NULL
HeLa	NULL
(	NULL
0.8	NULL
x	NULL
10°/ml	NULL
}	NULL
cells	NULL
were	NULL
used	NULL
to	NULL
prepare	NULL
extracts	NULL
from	NULL
isolated	NULL
nuclei	NULL
in	NULL
buffer	NULL
H	NULL
(	NULL
Waterman	NULL
and	NULL
Jones	NULL
1990	NULL
}	NULL
.	NULL

Nuclei	NULL
were	NULL
extracted	NULL
with	NULL
60	NULL
ml	NULL
of	NULL
buffer	NULL
D	NULL
(	NULL
50	NULL
mm	NULL
Tris-HCl	NULL
at	NULL
pH	NULL
7.5	NULL
,	NULL
0.42	NULL
m	NULL
KCl	NULL
,	NULL
5	NULL
mm	NULL
MgC	NULL
]	NULL
,	NULL
0.1	NULL
mm	NULL
EDTA	NULL
,	NULL
2	NULL
mm	NULL
DTT	NULL
,	NULL
0.1	NULL
mm	NULL
PMSF	NULL
,	NULL
10	NULL
%	NULL
sucrose	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
)	NULL
and	NULL
soluble	NULL
proteins	NULL
precipitated	NULL
by	NULL
ammonium	NULL
sulfate	NULL
(	NULL
52	NULL
%	NULL
final	NULL
)	NULL
.	NULL

Precipitated	NULL
protein	NULL
was	NULL
resuspended	NULL
in	NULL
7.5	NULL
ml	NULL
of	NULL
HM	NULL
0	NULL
m	NULL
buffer	NULL
(	NULL
25	NULL
ram	NULL
HEPES	NULL
at	NULL
pH	NULL
8	NULL
,	NULL
12.5	NULL
mm	NULL
MgCl	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
mm	NULL
DTT	NULL
,	NULL
0.1	NULL
mm	NULL
PMSF	NULL
)	NULL
and	NULL
dialyzed	NULL
against	NULL
HM	NULL
buffer	NULL
plus	NULL
100	NULL
mm	NULL
KCl	NULL
(	NULL
HM	NULL
0.1	NULL
m	NULL
)	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
extract	NULL
was	NULL
spun	NULL
in	NULL
a	NULL
Sorvall	NULL
$	NULL
$	NULL
-34	NULL
rotor	NULL
at	NULL
17,000	NULL
rpm	NULL
for	NULL
15	NULL
min	NULL
and	NULL
the	NULL
soluble	NULL
extract	NULL
aliquoted	NULL
,	NULL
frozen	NULL
under	NULL
liquid	NULL
nitrogen	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

Spl	NULL
was	NULL
purified	NULL
from	NULL
either	NULL
Jurkat	NULL
or	NULL
HeLa	NULL
nuclei	NULL
using	NULL
sequential	NULL
lectin	NULL
(	NULL
Jackson	NULL
and	NULL
Tjian	NULL
1989	NULL
)	NULL
and	NULL
DNA	NULL
affinity	NULL
(	NULL
Ka-donaga	NULL
and	NULL
Tjian	NULL
1986	NULL
)	NULL
chromatography	NULL
.	NULL

All	NULL
steps	NULL
were	NULL
carried	NULL
out	NULL
at	NULL
4°C	NULL
.	NULL

Briefly	NULL
,	NULL
nuclei	NULL
from	NULL
8	NULL
to	NULL
12	NULL
liters	NULL
of	NULL
cells	NULL
were	NULL
extracted	NULL
with	NULL
60	NULL
ml	NULL
of	NULL
buffer	NULL
D	NULL
(	NULL
0.42	NULL
m	NULL
KCI	NULL
)	NULL
and	NULL
loaded	NULL
directly	NULL
onto	NULL
a	NULL
5-ml	NULL
WGA	NULL
column	NULL
(	NULL
Vector	NULL
Labs	NULL
)	NULL
as	NULL
described	NULL
.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
three	NULL
column	NULL
volumes	NULL
of	NULL
buffer	NULL
D	NULL
,	NULL
three	NULL
volumes	NULL
of	NULL
buffer	NULL
Z	NULL
'	NULL
0.1	NULL
m	NULL
(	NULL
25	NULL
mm	NULL
HEPES	NULL
at	NULL
pH	NULL
8	NULL
,	NULL
12.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mm	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
mm	NULL
DTT	NULL
,	NULL
0.1	NULL
mm	NULL
PMSF	NULL
,	NULL
0.1	NULL
%	NULL
NP-40	NULL
,	NULL
containing	NULL
100	NULL
mm	NULL
KCI	NULL
}	NULL
with	NULL
10	NULL
um	NULL
ZnCl	NULL
,	NULL
and	NULL
the	NULL
bound	NULL
protein	NULL
was	NULL
eluted	NULL
with	NULL
buffer	NULL
Z	NULL
'	NULL
0.1	NULL
m	NULL
containing	NULL
300	NULL
mm	NULL
GIcNAc	NULL
(	NULL
Calbiochem	NULL
)	NULL
.	NULL

The	NULL
eluted	NULL
protein	NULL
was	NULL
pooled	NULL
,	NULL
incubated	NULL
with	NULL
poly	NULL
{	NULL
d	NULL
{	NULL
I-C	NULL
)	NULL
]	NULL
(	NULL
30	NULL
pg/m1	NULL
)	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
and	NULL
loaded	NULL
directly	NULL
onto	NULL
a	NULL
l-ml	NULL
Spl	NULL
DNA-affinity	NULL
column	NULL
.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
Z	NULL
'	NULL
0.1	NULL
M	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
was	NULL
eluted	NULL
with	NULL
sequential	NULL
steps	NULL
of	NULL
Z	NULL
'	NULL
0.8	NULL
mM	NULL
buffer	NULL
.	NULL

Spl	NULL
was	NULL
purified	NULL
to	NULL
near	NULL
homogeneity	NULL
by	NULL
this	NULL
process	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
silver	NULL
staining	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

GENES	NULL
&	NULL
DEVELOPMENT	NULL
2101	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Sheridan	NULL
et	NULL
al	NULL
.	NULL

Preparation	NULL
of	NULL
Drosophila	NULL
$	NULL
-190	NULL
extract	NULL
for	NULL
chromatin	NULL
reconstitution	NULL
The	NULL
$	NULL
-190	NULL
extract	NULL
was	NULL
prepared	NULL
from	NULL
Drosophila	NULL
embryos	NULL
[	NULL
from	NULL
Canton-	NULL
$	NULL
wild-type	NULL
flies	NULL
)	NULL
as	NULL
described	NULL
(	NULL
Kamakaka	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
;	NULL
Bulger	NULL
and	NULL
Kadonaga	NULL
1994	NULL
)	NULL
.	NULL

To	NULL
summarize	NULL
,	NULL
four	NULL
to	NULL
six	NULL
batches	NULL
of	NULL
embryos	NULL
(	NULL
collected	NULL
every	NULL
6	NULL
hr	NULL
;	NULL
~85	NULL
grams	NULL
)	NULL
were	NULL
harvested	NULL
in	NULL
nylon	NULL
mesh	NULL
discs	NULL
with	NULL
water	NULL
and	NULL
dechorionated	NULL
by	NULL
immersion	NULL
in	NULL
1:1	NULL
bleach/water	NULL
for	NULL
90	NULL
sec	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
embryos	NULL
were	NULL
rinsed	NULL
thoroughly	NULL
immediately	NULL
with	NULL
water	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
quick	NULL
rinse	NULL
with	NULL
l-liter	NULL
embryo	NULL
wash	NULL
buffer	NULL
[	NULL
0.7	NULL
%	NULL
(	NULL
wt/vol	NULL
}	NULL
NaCl	NULL
,	NULL
0.04	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
embryos	NULL
were	NULL
transferred	NULL
to	NULL
an	NULL
800-ral	NULL
beaker	NULL
,	NULL
and	NULL
the	NULL
remaining	NULL
steps	NULL
were	NULL
carried	NULL
out	NULL
on	NULL
ice	NULL
or	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
embryos	NULL
were	NULL
resuspended	NULL
with	NULL
a	NULL
glass	NULL
rod	NULL
in	NULL
500	NULL
ml	NULL
of	NULL
embryo	NULL
wash	NULL
buffer	NULL
and	NULL
allowed	NULL
to	NULL
settle	NULL
,	NULL
and	NULL
the	NULL
buffer	NULL
was	NULL
removed	NULL
by	NULL
aspiration	NULL
.	NULL

This	NULL
was	NULL
repeated	NULL
once	NULL
more	NULL
with	NULL
embryo	NULL
wash	NULL
buffer	NULL
and	NULL
then	NULL
twice	NULL
with	NULL
500	NULL
ml	NULL
of	NULL
saline	NULL
wash	NULL
buffer	NULL
(	NULL
0.7	NULL
%	NULL
NaCl	NULL
)	NULL
.	NULL

This	NULL
washing/equilibration	NULL
procedure	NULL
was	NULL
repeated	NULL
two	NULL
more	NULL
times	NULL
with	NULL
500	NULL
ml	NULL
each	NULL
of	NULL
buffer	NULL
R	NULL
(	NULL
10	NULL
mm	NULL
HEPES	NULL
at	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mm	NULL
KCI	NULL
,	NULL
1.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mm	NULL
EGTA	NULL
,	NULL
10	NULL
mm	NULL
B-glycerophosphate	NULL
,	NULL
1	NULL
mm	NULL
DTT	NULL
,	NULL
0.2	NULL
mm	NULL
PMSF	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

One	NULL
final	NULL
100-ml	NULL
wash	NULL
with	NULL
buffer	NULL
R	NULL
was	NULL
carried	NULL
out	NULL
.	NULL

The	NULL
embryos	NULL
were	NULL
then	NULL
transferred	NULL
to	NULL
a	NULL
Bellco	NULL
Dounce	NULL
homogenizer	NULL
(	NULL
40	NULL
ml	NULL
)	NULL
and	NULL
disrupted	NULL
with	NULL
15	NULL
strokes	NULL
with	NULL
pestle	NULL
B	NULL
followed	NULL
by	NULL
40	NULL
strokes	NULL
with	NULL
pestle	NULL
A	NULL
.	NULL

The	NULL
homogenate	NULL
was	NULL
centrifuged	NULL
in	NULL
Falcon	NULL
2059	NULL
tubes	NULL
in	NULL
a	NULL
Sorvall	NULL
SS-34	NULL
rotor	NULL
at	NULL
8000	NULL
rpm	NULL
for	NULL
5	NULL
min	NULL
and	NULL
the	NULL
cloudy	NULL
,	NULL
yellow	NULL
cytoplasmic	NULL
fraction	NULL
was	NULL
collected	NULL
.	NULL

The	NULL
MgCl	NULL
,	NULL
concentration	NULL
was	NULL
adjusted	NULL
from	NULL
1.5	NULL
to	NULL
7	NULL
mm	NULL
and	NULL
the	NULL
extract	NULL
subjected	NULL
to	NULL
high	NULL
speed	NULL
centrifugation	NULL
in	NULL
a	NULL
Beckman	NULL
SW55	NULL
rotor	NULL
at	NULL
45,000	NULL
rpm	NULL
(	NULL
192,000g	NULL
)	NULL
for	NULL
2.25	NULL
hr	NULL
at	NULL
4°C	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
clarified	NULL
yellow	NULL
liquid	NULL
was	NULL
collected	NULL
and	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
,	NULL
thawed	NULL
in	NULL
water	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
a	NULL
second	NULL
high	NULL
speed	NULL
spin	NULL
{	NULL
192,000g	NULL
)	NULL
.	NULL

The	NULL
Drosophila	NULL
§-190	NULL
extract	NULL
was	NULL
collected	NULL
,	NULL
frozen	NULL
in	NULL
aliquots	NULL
in	NULL
liquid	NULL
nitrogen	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

Reconstitution	NULL
of	NULL
chromatin	NULL
onto	NULL
HIV-1	NULL
double-stranded	NULL
DNA	NULL
The	NULL
Drosophila	NULL
$	NULL
-190	NULL
extract	NULL
contains	NULL
low	NULL
levels	NULL
of	NULL
both	NULL
core	NULL
histones	NULL
and	NULL
histone	NULL
H1	NULL
and	NULL
must	NULL
be	NULL
supplemented	NULL
with	NULL
exog-enous	NULL
purified	NULL
core	NULL
histones	NULL
and	NULL
histone	NULL
H1	NULL
to	NULL
assemble	NULL
nucleosomal	NULL
cores	NULL
with	NULL
high	NULL
efficiency	NULL
(	NULL
Kamakaka	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

Core	NULL
histone	NULL
and	NULL
histone	NULL
H1	NULL
components	NULL
were	NULL
purified	NULL
according	NULL
to	NULL
the	NULL
procedures	NULL
of	NULL
Laybourn	NULL
and	NULL
Kadonaga	NULL
(	NULL
1991	NULL
)	NULL
and	NULL
Croston	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Standard	NULL
reconstitution	NULL
reactions	NULL
were	NULL
performed	NULL
with	NULL
pBR322	NULL
plasmids	NULL
containing	NULL
HIV-1	NULL
sequence	NULL
from	NULL
position	NULL
-	NULL
340	NULL
to	NULL
+80	NULL
relative	NULL
to	NULL
the	NULL
RNA	NULL
start	NULL
site	NULL
,	NULL
and	NULL
either	NULL
the	NULL
CAT	NULL
gene	NULL
{	NULL
5.1kB	NULL
LTRCATAH	NULL
;	NULL
,	NULL
)	NULL
or	NULL
luciferase	NULL
gene	NULL
(	NULL
6.7	NULL
kB	NULL
HIV-1/	NULL
LUC	NULL
}	NULL
;	NULL
the	NULL
results	NULL
obtained	NULL
were	NULL
the	NULL
same	NULL
with	NULL
either	NULL
plasmid	NULL
DNA	NULL
.	NULL

Typical	NULL
reconstitution	NULL
reactions	NULL
contained	NULL
150	NULL
wl	NULL
§-190	NULL
extract	NULL
(	NULL
~3.5	NULL
mg	NULL
)	NULL
,	NULL
which	NULL
was	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
27°C-30°C	NULL
with	NULL
purified	NULL
Drosophila	NULL
core	NULL
histones	NULL
(	NULL
2-2.3	NULL
ug	NULL
)	NULL
and	NULL
histone	NULL
HI	NULL
(	NULL
0.6	NULL
ug	NULL
)	NULL
in	NULL
buffer	NULL
R	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
400	NULL
pl	NULL
.	NULL

This	NULL
S-190	NULL
mixture	NULL
was	NULL
then	NULL
used	NULL
in	NULL
a	NULL
reconstitution	NULL
reaction	NULL
{	NULL
500	NULL
pul	NULL
final	NULL
volume	NULL
)	NULL
containing	NULL
DNA	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
,	NULL
ATP	NULL
(	NULL
3	NULL
mm	NULL
,	NULL
Sigma	NULL
)	NULL
,	NULL
creatine	NULL
phosphate	NULL
(	NULL
30	NULL
mm	NULL
,	NULL
Sigma	NULL
)	NULL
,	NULL
creatine	NULL
kinase	NULL
{	NULL
1	NULL
pg/ml	NULL
,	NULL
Sigma	NULL
}	NULL
,	NULL
and	NULL
either	NULL
HM	NULL
0.1	NULL
m	NULL
buffer	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
various	NULL
protein	NULL
fractions	NULL
.	NULL

The	NULL
HM	NULL
0.1m	NULL
buffer/protein	NULL
mixture	NULL
was	NULL
no	NULL
more	NULL
than	NULL
15	NULL
%	NULL
of	NULL
the	NULL
final	NULL
reaction	NULL
volume	NULL
and	NULL
contained	NULL
the	NULL
following	NULL
concentration	NULL
of	NULL
proteins	NULL
as	NULL
indicated	NULL
:	NULL
3	NULL
pg/ml	NULL
SpIFJ	NULL
,	NULL
15	NULL
nm	NULL
affinity	NULL
purified	NULL
Spl	NULL
,	NULL
15	NULL
nm	NULL
recombinant	NULL
Spl	NULL
(	NULL
Promega	NULL
}	NULL
,	NULL
100	NULL
nm	NULL
LEF-1	NULL
,	NULL
250	NULL
nm	NULL
HMG-88	NULL
,	NULL
80	NULL
nm	NULL
GST/Ets-1	NULL
,	NULL
and	NULL
20	NULL
nm	NULL
TFE-3	NULL
.	NULL

The	NULL
MgCl	NULL
,	NULL
concentration	NULL
was	NULL
adjusted	NULL
to	NULL
7	NULL
mM	NULL
final	NULL
concentration	NULL
.	NULL

In	NULL
the	NULL
reactions	NULL
shown	NULL
in	NULL
this	NULL
paper	NULL
,	NULL
2102	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
the	NULL
factors	NULL
were	NULL
allowed	NULL
to	NULL
bind	NULL
their	NULL
sites	NULL
on	NULL
DNA	NULL
for	NULL
10-20	NULL
min	NULL
on	NULL
ice	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
S-190	NULL
assembly	NULL
extract	NULL
and	NULL
purified	NULL
histones	NULL
;	NULL
however	NULL
we	NULL
have	NULL
subsequently	NULL
determined	NULL
that	NULL
this	NULL
preincubation	NULL
step	NULL
is	NULL
unnecessary	NULL
and	NULL
that	NULL
the	NULL
factors	NULL
can	NULL
be	NULL
added	NULL
simultaneously	NULL
with	NULL
the	NULL
assembly	NULL
extract	NULL
without	NULL
affecting	NULL
the	NULL
results	NULL
.	NULL

The	NULL
reconstitution	NULL
reaction	NULL
was	NULL
carried	NULL
out	NULL
for	NULL
4.5-5	NULL
hr	NULL
at	NULL
27°C-30°C	NULL
and	NULL
aliquots	NULL
of	NULL
the	NULL
resulting	NULL
HIV-1	NULL
nucleosomal	NULL
templates	NULL
were	NULL
used	NULL
for	NULL
subsequent	NULL
micrococcal	NULL
nuclease	NULL
analysis	NULL
and	NULL
in	NULL
vitro	NULL
transcription	NULL
reactions	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
reactions	NULL
The	NULL
HIV-1	NULL
enhancer	NULL
construct	NULL
pHIV-1/LUC	NULL
(	NULL
100	NULL
ng	NULL
)	NULL
,	NULL
either	NULL
as	NULL
plasmid	NULL
DNA	NULL
or	NULL
as	NULL
chromatin-reconstituted	NULL
DNA	NULL
(	NULL
taken	NULL
as	NULL
a	NULL
20-ul	NULL
aliquot	NULL
of	NULL
the	NULL
chromatin	NULL
reconstitution	NULL
reaction	NULL
}	NULL
,	NULL
was	NULL
mixed	NULL
in	NULL
a	NULL
100-pl	NULL
reaction	NULL
(	NULL
final	NULL
volume	NULL
)	NULL
containing	NULL
20	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
8	NULL
)	NULL
,	NULL
6	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
30-70	NULL
mm	NULL
KCI	NULL
,	NULL
300	NULL
ng	NULL
of	NULL
poly	NULL
{	NULL
d	NULL
{	NULL
I-C	NULL
)	NULL
]	NULL
,	NULL
2.5	NULL
%	NULL
polyvinyl	NULL
alcohol	NULL
,	NULL
80-100	NULL
ug	NULL
of	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
,	NULL
and	NULL
50	NULL
ng	NULL
«	NULL
-globin	NULL
DNA	NULL
.	NULL

Preinitiation	NULL
complexes	NULL
were	NULL
allowed	NULL
to	NULL
form	NULL
for	NULL
20	NULL
min	NULL
at	NULL
25°C	NULL
,	NULL
and	NULL
the	NULL
templates	NULL
were	NULL
transcribed	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
following	NULL
the	NULL
addition	NULL
of	NULL
ribonucleotides	NULL
{	NULL
0.4	NULL
mm	NULL
final	NULL
)	NULL
.	NULL

Transcription	NULL
on	NULL
naked	NULL
DNA	NULL
templates	NULL
shown	NULL
in	NULL
Figure	NULL
4B	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
the	NULL
same	NULL
ratio	NULL
of	NULL
recombinant	NULL
LEF-1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
Sp1F	NULL
)	NULL
proteins	NULL
to	NULL
DNA	NULL
as	NULL
described	NULL
above	NULL
for	NULL
the	NULL
chromatin	NULL
reconstitution	NULL
reactions	NULL
.	NULL

The	NULL
resulting	NULL
RNAs	NULL
were	NULL
detected	NULL
using	NULL
*°P-labeled	NULL
HIV-1	NULL
primer	NULL
(	NULL
position	NULL
+50	NULL
to	NULL
+81	NULL
)	NULL
and	NULL
a-globin	NULL
primer	NULL
in	NULL
a	NULL
mixed	NULL
primer	NULL
extension	NULL
assay	NULL
(	NULL
Waterman	NULL
and	NULL
Jones	NULL
1990	NULL
}	NULL
.	NULL

The	NULL
reverse-transcribed	NULL
DNA	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
8	NULL
%	NULL
urea/polyacrylamide	NULL
gels	NULL
,	NULL
visualized	NULL
by	NULL
autoradiography	NULL
,	NULL
and	NULL
quantitated	NULL
following	NULL
PhosphorImager	NULL
scanning	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

MNase	NULL
analysis	NULL
of	NULL
reconstituted	NULL
chromatin	NULL
This	NULL
approach	NULL
was	NULL
used	NULL
to	NULL
assess	NULL
the	NULL
efficiency	NULL
of	NULL
nucleosome	NULL
assembly	NULL
and	NULL
determine	NULL
the	NULL
optimal	NULL
levels	NULL
of	NULL
core	NULL
histones	NULL
and	NULL
histone	NULL
H1	NULL
for	NULL
chromatin	NULL
reconstitution	NULL
.	NULL

Partial	NULL
digestion	NULL
of	NULL
reconstituted	NULL
chromatin	NULL
with	NULL
MNase	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
3	NULL
mM	NULL
CaCl	NULL
,	NULL
with	NULL
an	NULL
empirically	NULL
determined	NULL
concentration	NULL
of	NULL
nuclease	NULL
(	NULL
8	NULL
x	NULL
10	NULL
~*	NULL
U/ml	NULL
)	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
time	NULL
points	NULL
ranging	NULL
between	NULL
2	NULL
and	NULL
25	NULL
min	NULL
,	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Figure	NULL
3	NULL
.	NULL

At	NULL
each	NULL
time	NULL
point	NULL
,	NULL
an	NULL
80-ul	NULL
aliquot	NULL
was	NULL
removed	NULL
and	NULL
the	NULL
reaction	NULL
was	NULL
terminated	NULL
by	NULL
addition	NULL
of	NULL
EDTA	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
50	NULL
mm	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
treated	NULL
sequentially	NULL
with	NULL
0.15	NULL
mg/ml	NULL
of	NULL
RNase	NULL
A	NULL
(	NULL
Boeh-ringer	NULL
Mannheim	NULL
}	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
then	NULL
50	NULL
ug/ml	NULL
of	NULL
proteinase	NULL
K	NULL
(	NULL
Sigma	NULL
)	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
resulting	NULL
DNA	NULL
fragments	NULL
were	NULL
deproteinized	NULL
and	NULL
resolved	NULL
on	NULL
a	NULL
1.25	NULL
%	NULL
agarose	NULL
gel	NULL
at	NULL
10	NULL
V/cm	NULL
for	NULL
2.5	NULL
hr	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
staining	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

Gel	NULL
mobility	NULL
shift-circular	NULL
permutation	NULL
assay	NULL
The	NULL
circular	NULL
permutation	NULL
vector	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
a	NULL
synthetic	NULL
double-stranded	NULL
TCR	NULL
«	NULL
enhancer	NULL
oligodeoxynucleo-tide	NULL
comprising	NULL
the	NULL
LEF-l-binding	NULL
site	NULL
into	NULL
the	NULL
pCY4	NULL
plasmid	NULL
(	NULL
Prentki	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
.	NULL

Double-stranded	NULL
DNA	NULL
probes	NULL
of	NULL
~230	NULL
bp	NULL
were	NULL
prepared	NULL
by	NULL
digestion	NULL
with	NULL
specific	NULL
restriction	NULL
endonu-cleases	NULL
,	NULL
followed	NULL
by	NULL
isolation	NULL
of	NULL
the	NULL
fragment	NULL
on	NULL
DES1	NULL
paper	NULL
,	NULL
labeling	NULL
with	NULL
[	NULL
°°P	NULL
]	NULL
ATP	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
,	NULL
and	NULL
purification	NULL
as	NULL
described	NULL
for	NULL
the	NULL
footprint	NULL
probes	NULL
above	NULL
.	NULL

Binding	NULL
reactions	NULL
{	NULL
15	NULL
ul	NULL
total	NULL
volume	NULL
)	NULL
contained	NULL
30	NULL
pg	NULL
of	NULL
the	NULL
specific	NULL
°°P	NULL
end-labeled	NULL
230-bp	NULL
double-stranded	NULL
pCY4	NULL
fragments	NULL
containing	NULL
the	NULL
TCRa	NULL
«	NULL
LEF-1-binding	NULL
site	NULL
(	NULL
1.5	NULL
x	NULL
10°	NULL
cpm/	NULL
reaction	NULL
;	NULL
7.5	NULL
x	NULL
10°	NULL
cpm/pug	NULL
)	NULL
mixed	NULL
with	NULL
250	NULL
ng	NULL
of	NULL
poly	NULL
{	NULL
d	NULL
{	NULL
(	NULL
A-T	NULL
)	NULL
]	NULL
in	NULL
25	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
8	NULL
)	NULL
,	NULL
6.25	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
mm	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
DTT	NULL
,	NULL
and	NULL
5	NULL
%	NULL
glycerol	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
prepared	NULL
on	NULL
ice	NULL
and	NULL
30	NULL
ng	NULL
of	NULL
the	NULL
specified	NULL
protein	NULL
fraction	NULL
was	NULL
added	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
,	NULL
mixed	NULL
with	NULL
3	NULL
pl	NULL
of	NULL
loading	NULL
buffer	NULL
{	NULL
10	NULL
mm	NULL
HEPES	NULL
at	NULL
pH	NULL
8	NULL
,	NULL
0.01	NULL
%	NULL
bromophenol	NULL
blue	NULL
,	NULL
50	NULL
%	NULL
glycerol	NULL
}	NULL
,	NULL
and	NULL
loaded	NULL
directly	NULL
onto	NULL
a	NULL
6	NULL
%	NULL
nondenaturing	NULL
poly-acrylamide	NULL
gel	NULL
containing	NULL
0.5	NULL
%	NULL
TBE	NULL
,	NULL
0.025	NULL
%	NULL
NP-40	NULL
,	NULL
and	NULL
5	NULL
%	NULL
glycerol	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
run	NULL
at	NULL
12.5	NULL
V/em	NULL
at	NULL
4°C	NULL
for	NULL
4	NULL
hr	NULL
.	NULL

For	NULL
the	NULL
competition	NULL
reactions	NULL
,	NULL
unlabeled	NULL
HIV-1	NULL
enhancer	NULL
oligodeoxy-nucleotides	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mix	NULL
before	NULL
the	NULL
protein	NULL
addition	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
exposed	NULL
for	NULL
autoradiography	NULL
.	NULL

The	NULL
relative	NULL
mobility	NULL
of	NULL
each	NULL
complex	NULL
was	NULL
calculated	NULL
from	NULL
the	NULL
ratio	NULL
of	NULL
the	NULL
mobilities	NULL
of	NULL
the	NULL
fastest	NULL
and	NULL
slowest	NULL
migrating	NULL
complexes	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
.	NULL

The	NULL
relative	NULL
mobility	NULL
was	NULL
used	NULL
to	NULL
estimate	NULL
the	NULL
bending	NULL
angles	NULL
for	NULL
each	NULL
complex	NULL
by	NULL
both	NULL
linear	NULL
interpolation	NULL
against	NULL
A-tract	NULL
DNA	NULL
standards	NULL
and	NULL
quantitative	NULL
analysis	NULL
as	NULL
described	NULL
by	NULL
Thompson	NULL
and	NULL
Landy	NULL
(	NULL
1988	NULL
)	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Tim	NULL
Mayall	NULL
for	NULL
his	NULL
efforts	NULL
related	NULL
to	NULL
this	NULL
project	NULL
and	NULL
for	NULL
insightful	NULL
discussions	NULL
,	NULL
and	NULL
to	NULL
various	NULL
members	NULL
of	NULL
the	NULL
Kadonaga	NULL
laboratory	NULL
for	NULL
their	NULL
help	NULL
and	NULL
advice	NULL
on	NULL
the	NULL
preparation	NULL
of	NULL
active	NULL
chromatin-assembly	NULL
extracts	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Sam	NULL
Darin	NULL
for	NULL
assistance	NULL
with	NULL
tissue	NULL
culture	NULL
and	NULL
Dirk	NULL
Albrecht	NULL
for	NULL
technical	NULL
assistance	NULL
,	NULL
and	NULL
we	NULL
are	NULL
grateful	NULL
to	NULL
members	NULL
of	NULL
both	NULL
the	NULL
Jones	NULL
and	NULL
Kadonaga	NULL
laboratories	NULL
for	NULL
their	NULL
comments	NULL
on	NULL
the	NULL
manu-script	NULL
.	NULL

This	NULL
work	NULL
was	NULL
funded	NULL
by	NULL
grants	NULL
to	NULL
K.A.J	NULL
.	NULL

from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
[	NULL
(	NULL
NIH	NULL
)	NULL
{	NULL
(	NULL
GM38166	NULL
and	NULL
CA54418	NULL
)	NULL
and	NULL
the	NULL
Mathers	NULL
Foundation	NULL
.	NULL

J.T.K	NULL
.	NULL

is	NULL
a	NULL
Presidential	NULL
Faculty	NULL
Fellow	NULL
and	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
NIH	NULL
{	NULL
GM46995	NULL
)	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
USC	NULL
section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

References	NULL
Adams	NULL
,	NULL
C.	NULL
and	NULL
J	NULL
.	NULL

Workman	NULL
.	NULL

1993	NULL
.	NULL

Nucleosome	NULL
displacement	NULL
in	NULL
transcription	NULL
.	NULL

Cell	NULL
72	NULL
;	NULL
305-308	NULL
.	NULL

Barton	NULL
,	NULL
M.	NULL
and	NULL
B.	NULL
Emerson	NULL
.	NULL

1994	NULL
.	NULL

Regulated	NULL
expression	NULL
of	NULL
the	NULL
B-globin	NULL
gene	NULL
locus	NULL
in	NULL
synthetic	NULL
nuclei	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

8	NULL
:	NULL
2453-2465	NULL
.	NULL

Barton	NULL
,	NULL
M.	NULL
,	NULL
N.	NULL
Madani	NULL
,	NULL
and	NULL
B.	NULL
Emerson	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
erythroid	NULL
protein	NULL
cGATA-1	NULL
functions	NULL
with	NULL
a	NULL
stage-specific	NULL
factor	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
chromatin-assembled	NULL
B-globin	NULL
genes	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

7	NULL
:	NULL
1796-1809	NULL
.	NULL

Bulger	NULL
,	NULL
M.	NULL
and	NULL
J.	NULL
Kadonaga	NULL
.	NULL

1994	NULL
.	NULL

Biochemical	NULL
reconstitution	NULL
of	NULL
chromatin	NULL
with	NULL
physiological	NULL
nucleosome	NULL
spacing	NULL
.	NULL

Methods	NULL
Mol	NULL
.	NULL

Genet	NULL
.	NULL

5	NULL
:	NULL
241-262	NULL
.	NULL

Carlsson	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Waterman	NULL
,	NULL
and	NULL
K.	NULL
Jones	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
LEF-1/TCF-la	NULL
HMG	NULL
protein	NULL
contains	NULL
a	NULL
context-dependent	NULL
activation	NULL
domain	NULL
that	NULL
induces	NULL
the	NULL
TCRa	NULL
«	NULL
enhancer	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

7	NULL
:	NULL
2418-2430	NULL
.	NULL

Clevers	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Oosterwegel	NULL
,	NULL
and	NULL
K.	NULL
Georgopoulos	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
factors	NULL
in	NULL
early	NULL
T-cell	NULL
development	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
14	NULL
:	NULL
591-596	NULL
.	NULL

Croston	NULL
,	NULL
G.	NULL
,	NULL
L.	NULL
Lira	NULL
,	NULL
and	NULL
J.	NULL
Kadonaga	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
general	NULL
method	NULL
for	NULL
purification	NULL
of	NULL
H1	NULL
histones	NULL
that	NULL
are	NULL
active	NULL
for	NULL
repression	NULL
of	NULL
basal	NULL
RNA	NULL
polymerase	NULL
II	NULL
transcription	NULL
.	NULL

Protein	NULL
Exp	NULL
.	NULL

Purific	NULL
.	NULL

2	NULL
:	NULL
162-169	NULL
.	NULL

El	NULL
Kharroubi	NULL
,	NULL
A.	NULL
and	NULL
E.	NULL
Verdin	NULL
.	NULL

1994	NULL
.	NULL

Protein-DNA	NULL
interactions	NULL
within	NULL
DNase	NULL
I-hypersensitive	NULL
sites	NULL
located	NULL
downstream	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
:	NULL
19916-19924	NULL
.	NULL

Felsenfeld	NULL
,	NULL
G.	NULL
1992	NULL
.	NULL

Chromatin	NULL
as	NULL
an	NULL
essential	NULL
part	NULL
of	NULL
the	NULL
transcriptional	NULL
mechanism	NULL
.	NULL

Nature	NULL
355	NULL
:	NULL
219-224	NULL
.	NULL

Chromatin-dependent	NULL
trans-activation	NULL
by	NULL
LEF-1	NULL
Fong	NULL
,	NULL
T.	NULL
and	NULL
B.	NULL
Emerson	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
erythroid-specific	NULL
protein	NULL
cGATA-1	NULL
mediates	NULL
distal	NULL
enhancer	NULL
activity	NULL
through	NULL
a	NULL
specialized	NULL
B-globin	NULL
TATA	NULL
box	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

6	NULL
:	NULL
521-532	NULL
.	NULL

Gerber	NULL
,	NULL
H.-P.	NULL
,	NULL
M.	NULL
Hagmann	NULL
,	NULL
K.	NULL
Seipel	NULL
,	NULL
O.	NULL
Georgiev	NULL
,	NULL
M.	NULL
West	NULL
,	NULL
Y.	NULL
Litingtung	NULL
,	NULL
W.	NULL
Schaffner	NULL
,	NULL
and	NULL
J.	NULL
Corden	NULL
.	NULL

1995	NULL
.	NULL

RNA	NULL
polymerase	NULL
II	NULL
C-terminal	NULL
domain	NULL
required	NULL
for	NULL
enhancer-driven	NULL
transcription	NULL
.	NULL

Nature	NULL
374	NULL
;	NULL
660-662	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1993	NULL
.	NULL

LEF-1	NULL
contains	NULL
an	NULL
activation	NULL
domain	NULL
that	NULL
stimulates	NULL
transcription	NULL
only	NULL
in	NULL
a	NULL
specific	NULL
context	NULL
of	NULL
factor-binding	NULL
sites	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12	NULL
:	NULL
4667-4676	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
Cox	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
HMG	NULL
domain	NULL
of	NULL
lymphoid	NULL
enhancer	NULL
factor	NULL
1	NULL
bends	NULL
DNA	NULL
and	NULL
facilitates	NULL
assembly	NULL
of	NULL
functional	NULL
nucleoprotein	NULL
structures	NULL
.	NULL

Cell	NULL
69	NULL
:	NULL
185-196	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Kingsley	NULL
,	NULL
J.	NULL
Kirshner	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1995	NULL
.	NULL

Assembly	NULL
and	NULL
function	NULL
of	NULL
a	NULL
TCRa	NULL
«	NULL
enhancer	NULL
complex	NULL
is	NULL
dependent	NULL
on	NULL
LEF-l-induced	NULL
DNA	NULL
bending	NULL
and	NULL
multiple	NULL
pro-tein-protein	NULL
interactions	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

9	NULL
:	NULL
995-1008	NULL
.	NULL

Grosschedl	NULL
,	NULL
R.	NULL
,	NULL
K.	NULL
Giese	NULL
,	NULL
and	NULL
J.	NULL
Pagel	NULL
.	NULL

1994	NULL
.	NULL

HMG	NULL
domain	NULL
pro-teins	NULL
:	NULL
Architectural	NULL
elements	NULL
in	NULL
the	NULL
assembly	NULL
of	NULL
nucleoprotein	NULL
structures	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

10	NULL
:	NULL
94-100	NULL
.	NULL

Izban	NULL
,	NULL
M.	NULL
and	NULL
D.	NULL
Luse	NULL
.	NULL

1991	NULL
.	NULL

Transcription	NULL
of	NULL
nucleosomal	NULL
templates	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
vitro	NULL
:	NULL
Inhibition	NULL
of	NULL
elongation	NULL
with	NULL
enhancement	NULL
of	NULL
sequence-specific	NULL
pausing	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
:	NULL
683-696	NULL
.	NULL

Jackson	NULL
,	NULL
S.	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1989	NULL
.	NULL

Purification	NULL
and	NULL
analysis	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
transcription	NULL
factors	NULL
by	NULL
using	NULL
wheat	NULL
germ	NULL
ag-glutinin	NULL
affinity	NULL
chromatography	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

86	NULL
:	NULL
1781-1785	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
and	NULL
B.	NULL
Peterlin	NULL
.	NULL

1994	NULL
.	NULL

Control	NULL
of	NULL
RNA	NULL
initiation	NULL
and	NULL
elongation	NULL
at	NULL
the	NULL
HIV-1	NULL
promoter	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

63	NULL
:	NULL
717-743	NULL
.	NULL

Kadonaga	NULL
,	NULL
J.	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1986	NULL
.	NULL

Affinity	NULL
purification	NULL
of	NULL
sequence-specific	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

831	NULL
5889-5893	NULL
.	NULL

Kamakaka	NULL
,	NULL
R.	NULL
,	NULL
M.	NULL
Bulger	NULL
,	NULL
and	NULL
J.	NULL
Kadonaga	NULL
.	NULL

1993	NULL
.	NULL

Potentiation	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
transcription	NULL
by	NULL
Gal4-VP16	NULL
during	NULL
but	NULL
not	NULL
after	NULL
DNA	NULL
replication	NULL
and	NULL
chromatin	NULL
assembly	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

7	NULL
:	NULL
1779-1795	NULL
.	NULL

Kelleher	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Flanagan	NULL
,	NULL
and	NULL
R.	NULL
Kornberg	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
novel	NULL
mediator	NULL
betwen	NULL
activator	NULL
proteins	NULL
and	NULL
the	NULL
RNA	NULL
polymerase	NULL
II	NULL
transcription	NULL
activator	NULL
protein	NULL
.	NULL

Cell	NULL
61	NULL
:	NULL
1209-1215	NULL
.	NULL

Kim	NULL
,	NULL
J.	NULL
,	NULL
F.	NULL
Gonzales-Scarano	NULL
,	NULL
S.	NULL
Zeichner	NULL
,	NULL
and	NULL
J.	NULL
Alwine	NULL
.	NULL

1993	NULL
.	NULL

Replication	NULL
of	NULL
type	NULL
1	NULL
human	NULL
immunodeficiency	NULL
viruses	NULL
containing	NULL
linker	NULL
substitution	NULL
mutations	NULL
in	NULL
the	NULL
-201	NULL
to	NULL
-130	NULL
region	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67	NULL
:	NULL
1658-1662	NULL
.	NULL

Koleske	NULL
,	NULL
A.	NULL
and	NULL
R.	NULL
Young	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
RNA	NULL
polymerase	NULL
II	NULL
holoenzyme	NULL
and	NULL
its	NULL
implications	NULL
for	NULL
gene	NULL
regulation	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

20	NULL
;	NULL
113-116	NULL
.	NULL

Laybourn	NULL
,	NULL
P.	NULL
and	NULL
J.	NULL
Kadonaga	NULL
.	NULL

1991	NULL
.	NULL

Role	NULL
of	NULL
nucleosomal	NULL
cores	NULL
and	NULL
histone	NULL
H1	NULL
in	NULL
regulation	NULL
of	NULL
transcription	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
.	NULL

Science	NULL
254	NULL
:	NULL
238-245.	NULL
.	NULL

1992	NULL
.	NULL

Threshold	NULL
phenomena	NULL
and	NULL
long	NULL
distance	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
.	NULL

Science	NULL
257	NULL
:	NULL
1682-1685	NULL
.	NULL

Muller	NULL
,	NULL
H.-P.	NULL
and	NULL
H.	NULL
Varmus	NULL
.	NULL

1994	NULL
,	NULL
DNA	NULL
bending	NULL
creates	NULL
favored	NULL
sites	NULL
for	NULL
retroviral	NULL
integration	NULL
:	NULL
An	NULL
explanation	NULL
for	NULL
preferred	NULL
insertion	NULL
sites	NULL
in	NULL
nucleosomes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13	NULL
:	NULL
4704-4714	NULL
.	NULL

Oosterwegel	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
van	NULL
der	NULL
Wetering	NULL
,	NULL
J.	NULL
Timmerman	NULL
,	NULL
A.	NULL
Kruis-beek	NULL
,	NULL
O.	NULL
Destree	NULL
,	NULL
F.	NULL
Meijlink	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
the	NULL
HMG	NULL
box	NULL
factors	NULL
TCF-1	NULL
and	NULL
LEF-1	NULL
during	NULL
murine	NULL
embryogenesis	NULL
.	NULL

Development	NULL
118	NULL
:	NULL
439-448	NULL
.	NULL

Paranjape	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Kamakaka	NULL
,	NULL
and	NULL
J.	NULL
Kadonaga	NULL
.	NULL

1994	NULL
.	NULL

Role	NULL
of	NULL
chromatin	NULL
structure	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
transcription	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

63	NULL
:	NULL
265-297	NULL
.	NULL

GENES	NULL
&	NULL
DEVELOPMENT	NULL
2103	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Sheridan	NULL
et	NULL
al	NULL
.	NULL

Pazin	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
Kamakaka	NULL
,	NULL
and	NULL
J.	NULL
Kadonaga	NULL
.	NULL

1994	NULL
.	NULL

ATP-dependent	NULL
nucleosome	NULL
reconfiguration	NULL
and	NULL
transcriptional	NULL
activation	NULL
from	NULL
-	NULL
preassembled	NULL
-	NULL
chromatin	NULL
-	NULL
templates	NULL
.	NULL

-	NULL
Science	NULL
266	NULL
:	NULL
2007-2011	NULL
.	NULL

Prentki	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Pham	NULL
,	NULL
and	NULL
D.	NULL
Galas	NULL
.	NULL

1987	NULL
.	NULL

Plasmid	NULL
permutation	NULL
vectors	NULL
to	NULL
monitor	NULL
DNA-bending	NULL
.	NULL

Nucleis	NULL
Acids	NULL
Res	NULL
.	NULL

15	NULL
:	NULL
10060	NULL
.	NULL

Ron	NULL
,	NULL
D.	NULL
and	NULL
H.	NULL
Dressler	NULL
.	NULL

1992.	NULL
pGSTag-	NULL
a	NULL
versatile	NULL
bacterial	NULL
expression	NULL
plasmid	NULL
for	NULL
enzymatic	NULL
labelling	NULL
of	NULL
recombinant	NULL
proteins	NULL
.	NULL

Biotechnology	NULL
13	NULL
:	NULL
866-869	NULL
.	NULL

Thompson	NULL
,	NULL
J.F	NULL
.	NULL

and	NULL
A.	NULL
Landy	NULL
.	NULL

1988	NULL
.	NULL

Empirical	NULL
estimation	NULL
of	NULL
protein-induced	NULL
DNA	NULL
bending	NULL
angles	NULL
:	NULL
Applications	NULL
to	NULL
lambda	NULL
site-specific	NULL
recombination	NULL
events	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16	NULL
:	NULL
9687-9705	NULL
.	NULL

Tjian	NULL
,	NULL
R.	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1994	NULL
.	NULL

Transcriptional	NULL
activation	NULL
:	NULL
A	NULL
complex	NULL
puzzle	NULL
with	NULL
few	NULL
easy	NULL
pieces	NULL
.	NULL

Cell	NULL
77	NULL
:	NULL
5-8	NULL
.	NULL

Travis	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Amsterdam	NULL
,	NULL
C.	NULL
Belanger	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1991	NULL
.	NULL

LEF-1	NULL
,	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
lymphoid-specific	NULL
protein	NULL
with	NULL
an	NULL
HMG	NULL
domain	NULL
,	NULL
regulates	NULL
T-cell	NULL
receptor	NULL
«	NULL
enhancer	NULL
function	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
:	NULL
880-894.	NULL
van	NULL
Genderen	NULL
,	NULL
C.	NULL
,	NULL
R.	NULL
Okamura	NULL
,	NULL
I	NULL
Farinas	NULL
,	NULL
R.-G	NULL
.	NULL

Quo	NULL
,	NULL
T.	NULL
Parslow	NULL
,	NULL
L.	NULL
Bruhn	NULL
,	NULL
and	NULL
R.	NULL
Grossched	NULL
]	NULL
1	NULL
.	NULL

1994	NULL
.	NULL

Development	NULL
of	NULL
several	NULL
organs	NULL
that	NULL
require	NULL
inductive	NULL
epithelial-mesenchy-mal	NULL
interactions	NULL
is	NULL
impaired	NULL
in	NULL
LEF-1-deficient	NULL
mice	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

8	NULL
:	NULL
2691-2703	NULL
.	NULL

Verdin	NULL
,	NULL
E.	NULL
1991	NULL
.	NULL

DNase	NULL
I-hypersensitive	NULL
sites	NULL
are	NULL
associated	NULL
with	NULL
both	NULL
long	NULL
terminal	NULL
repeats	NULL
and	NULL
with	NULL
the	NULL
intragenic	NULL
enhancer	NULL
of	NULL
integrated	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65	NULL
:	NULL
6790-6799	NULL
.	NULL

Verdin	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
Paras	NULL
,	NULL
and	NULL
C.	NULL
Van	NULL
Lint	NULL
.	NULL

1993	NULL
.	NULL

Chromatin	NULL
disruption	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
during	NULL
transcriptional	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12	NULL
:	NULL
3249-3259	NULL
.	NULL

Waterman	NULL
,	NULL
M.	NULL
and	NULL
K.	NULL
Jones	NULL
.	NULL

1990	NULL
.	NULL

Purification	NULL
of	NULL
TCF-la	NULL
,	NULL
a	NULL
T-cell-specific	NULL
transcription	NULL
factor	NULL
that	NULL
activates	NULL
the	NULL
T-cell	NULL
receptor	NULL
Ca	NULL
gene	NULL
enhancer	NULL
in	NULL
a	NULL
context-dependent	NULL
manner	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

2	NULL
;	NULL
621-636	NULL
.	NULL

Waterman	NULL
,	NULL
M.L	NULL
.	NULL

,	NULL
W.H	NULL
.	NULL

Fischer	NULL
,	NULL
and	NULL
K.A	NULL
.	NULL

Jones	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
thymus-specific	NULL
member	NULL
of	NULL
the	NULL
HMG	NULL
protein	NULL
family	NULL
regulates	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
receptor	NULL
C	NULL
alpha	NULL
enhancer	NULL
,	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
:	NULL
656-669	NULL
.	NULL

Zeichner	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Kim	NULL
,	NULL
and	NULL
J.	NULL
Alwine	NULL
.	NULL

1991a	NULL
.	NULL

Linker-scanning	NULL
mu-tational	NULL
analysis	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65	NULL
:	NULL
2436-2444.	NULL
.	NULL

1991b	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
competition	NULL
and	NULL
linker	NULL
scanning	NULL
mutagenesis	NULL
.	NULL

Gene	NULL
Expr	NULL
.	NULL

1	NULL
:	NULL
15-27	NULL
.	NULL

Zhou	NULL
,	NULL
P.	NULL
,	NULL
C.	NULL
Bryne	NULL
,	NULL
J.	NULL
Jacobs	NULL
,	NULL
and	NULL
E.	NULL
Fuchs	NULL
.	NULL

1995	NULL
.	NULL

Lymphoid	NULL
enhancer	NULL
factor	NULL
1	NULL
directs	NULL
hair	NULL
follicle	NULL
patterning	NULL
and	NULL
epithe-lial	NULL
cell	NULL
fate	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

9	NULL
:	NULL
570-583	NULL
.	NULL

2104	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
>	NULL
t	NULL
N-t	NULL
$	NULL
&	NULL
Development	NULL
Activation	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
by	NULL
the	NULL
LEF-1	NULL
HMG	NULL
protein	NULL
on	NULL
nucleosome-assembled	NULL
DNA	NULL
in	NULL
vitro	NULL
.	NULL

P	NULL
L	NULL
Sheridan	NULL
,	NULL
C	NULL
T	NULL
Sheline	NULL
,	NULL
K	NULL
Cannon	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1995	NULL
,	NULL
9	NULL
:	NULL
Access	NULL
the	NULL
most	NULL
recent	NULL
version	NULL
at	NULL
doi:10.1101/gad.9.1	NULL
7.2090	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
42	NULL
articles	NULL
,	NULL
20	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
/genesdev.cshlp.org/content/9/17/2090.full.htmli	NULL
#	NULL
ref-list-1	NULL
License	NULL
Email	NULL
Alerting	NULL
_	NULL
Receive	NULL
free	NULL
email	NULL
alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
-	NULL
sign	NULL
up	NULL
in	NULL
the	NULL
box	NULL
at	NULL
the	NULL
top	NULL
Service	NULL
-	NULL
``	NULL
ight	NULL
corner	NULL
of	NULL
the	NULL
article	NULL
or	NULL
click	NULL
here	NULL
.	NULL

CRISPR	NULL
KO	NULL
,	NULL
CRISPRa	NULL
,	NULL
CRISPRi	NULL
libraries	NULL
.	NULL

CELLECTA	NULL
Custom	NULL
or	NULL
genome-wide	NULL
.	NULL

Copyright	NULL
©	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL

